eremedyenterprise.comeremedyenterprise.com/images/johnrobertscv.doc · web view1988 - 1993...

Prepared: December 9, 2014University of California, San Francisco

CURRICULUM VITAE

Name: John P Roberts, MD

Position: Professor, Step 7SurgerySchool of Medicine

Address: Box 0780505 Parnassus Ave, Moffitt, M896University of California, San FranciscoSan Francisco, CA 94143

Voice: 353-9321Fax: 353-8709email: [email protected]

EDUCATION

1972 - 1976 Stanford University B.S. Biology

1976 - 1980 University of California, San Diego

M.D. Medicine

1980 - 1983 University of Washington, Seattle

Resident Surgery

1983 - 1985 Cornell University, New York Fellow Research

1985 - 1986 University of Washington, Seattle

Resident Surgery

1986 - 1987 University of Minnesota, Minneapolis

Fellow Transplant

LICENSES, CERTIFICATION1981 National Board Medical Examination

1988 Medical License (G062500)

1988 Initial Board Certification (33026)

1997 Board Certificate (33026) Recertification

2006 Fluoroscopy X-Ray Supervisor and Operator (RHC 160235)

2006 Board Certificate (33026) Recertification

PRINCIPAL POSITIONS HELD

1988 - 1993 University of California, San Francisco

Assistant Professor

In Residence

1 of 60

Prepared: December 9, 20141993 - 1997 University of California, San

FranciscoAssociate Professor

In Residence


Full Professor In Residence

2004 - present University of California, San Francisco

Full Professor Ladder

OTHER POSITIONS HELD CONCURRENTLY


Program Director, Abdominal Transplant Fellowship Program

Surgery, Division of Transplant

1995 - 2002 California Pacific Medical Center, San Francisco

Surgical Director, Liver Transplantation

1999 - present University of California, San Francisco

Chief, Division of Transplantation

1999 - present UCSF Medical Center Director, Division of Transplant

1999 - present UCSF Medical Center Surgical Director, Liver Transplant Program

2009 - present Children's Hospital Central California, Madera, CA

Consulting

HONORS AND AWARDS

1977 U.S. National Water Polo Team

1991 Chief Resident Teaching Award, Department of Surgery

University of California, San Francisco

1992 Chief Resident Teaching Award, Department of Surgery


2001 Best Doctors in America (2001-2012) Best Doctors, Aiken, South Carolina

2005 Exceptional Physician Award University of California, San Francisco Medical Center

2007 Author of the 40th Anniversary Landmark paper Winter Simulation Conference 2007

2009 American Liver Foundation (3-14-2009) Honoree, Salute to Excellence

2011 Top Doctor, in top 1% in nation in transplant specialty

U.S. News and World Report

2 of 60

Prepared: December 9, 2014KEYWORDS/AREAS OF INTEREST

Hepatocellular carcinoma, tumor surveillance, liver transplantation, living donor, orthotopic liver transplantation, ethical issues in liver transplantation, biliary atresia, immunosuppression, expanded criteria donor transplantation, hepatitis C and hepatitis B infection, pediatric liver transplantation, kidney transplantation, HLA matching, organ procurement, intestine transplantation, allograft rejection, organ allocation, cost of transplantation.

PROFESSIONAL ACTIVITIESCLINICAL

1999-present, Director of Abdominal Transplantation, San Francisco, CA, UCSF Medical Center; Chief, Division of Transplantation, Department of Surgery: I have served as the Division Chief of Transplantation since 1999 with overall responsibility for all clinical activities related to kidney, liver, pancreas, islet cell, and intestinal small bowel transplantation.

1988-present, Attending Physician, San Francisco, CA, UCSF Medical Center: I attend 16 weeks out of the year on the transplant services. I have been doing this for the past 23 years. I have performed more than 500 deceased donor transplants (1988-present) and more than 150 living donor liver transplants (1997-present).

SUMMARY OF CLINICAL ACTIVITIES

My clinical activities have been related to the development of the transplant service. The program that I have taken direct responsibility for is the living donor liver transplant program. This high visibility program presents significant risks and benefits to the donor, recipient, and the institution. With a cautious approach, our program now has done a large number of the operations. Our results in this program are arguably the best in the world. Currently we are a large contributor of patients to the NIH funded Adult to Adult Living Donor Liver Transplant Study group.

PROFESSIONAL ORGANIZATIONSMemberships

1987 - present Henry Harkins Surgical Society

1987 - present World Association of Hepato-Pancreato-Biliary Surgeons

1989 - present Howard C. Naffziger Surgical Society

1990 - present Transplantation Society

1991 - present Fellow American College of Surgeons

1991 - present San Francisco Surgical Society

1992 - present American Society of Transplant Surgeons

1992 - present International Liver Transplantation Society

1992 - present Pacific Coast Surgical Association

1993 - 2005 International Society of Surgery

1994 - 2011 Society of University Surgeons

1995 - present Society for Surgery of the Alimentary Tract

3 of 60

Prepared: December 9, 20141995 - present American Hepato-Pancreato-Biliary Association

2001 - present Fellow, American Surgical Association

2003 - present American Association for the Study of Liver Diseases

1990 - 2011 Association for Academic Surgery

1990 - 2011 San Francisco Medical Society

1995 - 2011 California Academy of Medicine

Service to Professional Organizations

1990 - 1991 Technology Assessment, Scientific Affairs, American Medical Association

Committee Member

1991 - 1994 Scientific Studies Committee, American Society of Transplant Surgeons

Committee Member

1998 - 1998 American Board of Surgery Associate Examiner

2002 - 2003 Bylaws Committee, American Society of Transplant Surgeons

Committee Chair

2002 - 2004 Liver & Intestine Committee, American Society of Transplantation

Committee Member

2003 - 2004 Development Committee, American Society of Transplant Surgeons

Committee Member

2003 - 2004 Governmental Policy Committee, American Society of Transplant Surgeons

Committee Member

2003 - 2005 Program Committee, American Surgical Association

Committee Member

2004 - 2006 Legislative Committee, American Society of Transplant Surgeons

Committee Chair

2004 - 2007 Board of Directors, American Society of Transplant Surgeons

Councilor at Large

2005 - 2006 OPTN Task Force, American Society of Transplant Surgeons

Task Force Member

2007 - 2010 Medical Advisory Committee, American Liver Foundation

Committee Chair

2008 - 2009 American Society of Transplant Surgeons President

2008 - 2009 Program Committee, American Surgical Association

Committee Chair

2008 - 2011 Organ Donation and Transplantation Alliance ASTS Representative

2010 - 2011 Donor Management Task Force Co-Chair

SERVICE TO PROFESSIONAL PUBLICATIONS1992 - 1997 Fujisawa Pharmaceutical, Publications Committee, member of Editorial

Committee

4 of 60

Prepared: December 9, 20141998 - 2001 Archives of Surgery, Member, Editorial Board

1999 - 2005 Liver Transplantation and Surgery, Member, Editorial Board

2003 - 2008 American Journal of Transplantation, Deputy Editor

2010 - 2014 Liver Transplantation (Co-Editor with Dr. Jack Lake)

INVITED PRESENTATIONSINTERNATIONAL

1993 U.S. Multicenter FK506 Trials in Liver Transplantation, International Liver Transplantation Society, Toronto, Canada

Invited Lecturer

1996 Three-Year Follow-up of the Primary Trial of FK506 in Liver Transplantation, International Society for Transplantation, Barcelona, Spain

Invited Lecturer

2002 The American Experience, International Congress of the Transplantation Society, Miami, FL

Invited Lecturer

2008 Resection and Transplantation of Hepatocellular Carcinoma, Columbia University College of Physicians and Surgeons: International Perspectives on Hepatic, Pancreatic and Biliary Surgery, New York City, NY

Invited Lecturer

2008 Living Donor Liver Transplantation, King Faisal Specialist Hospital & Research Center in Riyadh, Saudi Arabia, Saudi Arabia

Invited Lecturer

2008 Living Donor Liver Transplantation, King Fahad Hospital (National Guard-Health Affair Hospital) in Riyadh, Saudi Arabia, Saudi Arabia

Invited Lecturer

2008 Living Donor Liver Transplantation, The Military Hospital in Riyadh, Saudi Arabia, Saudi Arabia

Invited Lecturer

2009 Living Donor Liver Transplantation, Bahrain Specialist Hospital in Bahrain

Invited Lecturer

2009 Living Donor Liver Transplantation, Saad Specialist Hospital in Al-Khobbar, Saudi Arabia

Invited Lecturer

2009 Liver Transplantation, Sultanate of Oman Ministry of Health Royal Hospital, Muscat, Oman, Saudi Arabia

Seminar Leader

2010 ILTS 2010 Congress, Hong Kong Invited Speaker

2011 Are Left Lobes Really Safer?: The Current US Dilemma, ILTS 2011 Congress, Spain

Invited Speaker

2012 Evolving Ethical Issues in Transplantation: 2012, Asian Pacific Association for the Study of the Liver (APASL 2012), Taiwan

Invited Speaker

2012 Over the Horizon – Future Directions in Liver Transplantation, Asian Pacific Association for the Study of the Liver (APASL 2012), Taiwan

Invited Speaker

2012 Daring to Dream - Making the Inconceivable a Reality, Invited Moderator

5 of 60

Prepared: December 9, 2014Asian Pacific Association for the Study of the Liver (APASL 2012), Taiwan

2012 Oral Presentation (Liver Transplantation and HCC Surgery), Asian Pacific Association for the Study of the Liver (APASL 2012), Taiwan

Invited Moderator

2012 MOT Rounds, Toronto General Hospital, Toronto, Ontario, Canada

Invited Speaker

2012 "The Introduction of Left Lobe in Adults: Pitfalls and Outcomes," 6th International Living Donor Abdominal Organ Transplantation: State of the Art, Puglia, Italy

Invited Speaker

2012 “Living Donor Liver Transplantation,” 6th International Living Donor Abdominal Organ Transplantation: State of the Art, Puglia, Italy

Session Chair

2013 "Liver transplantation for hepatocellular carcinoma: should criteria be expanded?" (Debate). The Annual Conference of the Israel Association for the Study of the Liver: Management of Cirrhosis. Tel Aviv, Israel, Oct. 2013

Invited Speaker

2014 "Staff Development/Mentorship: How to Grow Clinical and Administrative Leaders," ASTS Advanced Leadership Development Program (ALDP), Webinar #3. Jan 2014

Invited Speaker

2014 "Time for New Criteria in an Era of Effective Loco-regional Therapy," 2014 Joint International Congress of ILTS, ELITA & LICAGE, London, England, June 2014

Invited Speaker

2014 "Should the Left Lobe Take Over the Right Lobe?" World Transplant Congress, San Francisco, CA July 2014

Invited Speaker

2014 "Liver: Living Donors and Partial Grafts" World Transplant Congress, San Francisco, CA, July 2014

Invited Moderator

2014 "Starting a Living Donor Chain with a Deceased Graft: A Proposal" 7th International Conference: Living Donor Abdominal Organ Transplantation, Padova, Italy. Sept 2014

Invited Speaker

2014 “Living Donor Liver Transplant Best Option for Small Children” 7th International Conference: Living Donor Abdominal Organ Transplantation, Padova, Italy. Sept 2014

Invited Speaker

NATIONAL

1994 The Effect of Postoperative Complications on the Cost of Liver Transplantation, American Society of Transplant Surgeons, Chicago, IL

Invited Lecturer

1994 Liver Transplantation, St. Francis Medical Center, Honolulu, HI

Invited Lecturer

1995 Liver Transplantation, Swedish Hospital, Seattle, WA Invited Lecturer

1996 Organ Allocation, Department of Health & Human Invited Lecturer

6 of 60

Prepared: December 9, 2014Services, Washington, D.C.

1996 Organ Allocation, University of Minnesota , Minneapolis, MN

Invited Lecturer

1996 Allocation of Livers, United Network for Organ Sharing, St. Louis, MO

Invited Lecturer

1996 Cost of Complications, University of North Carolina, Raleigh, NC

Invited Lecturer

1996 Liver Allocation and Organ Donation, Department of Health & Human Services, Washington, D.C.

Invited Lecture

1997 Transplant Professionals and Health Care Payers, Department of Health & Human Services, Washington, D.C.

Invited Lecturer

1997 Effect of Donor and Recipient Factors on Organ and Patient Survival - Liver, Seventh Annual Postgraduate Course: New York 1997, New York, NY

Invited Lecturer

1998 Hepatocellular Carcinoma, American Association for the Study of Liver Diseases, St. Louis, MO

Invited Lecturer

1999 Organ Allocation, Department of Health & Human Services, Washington, D.C.

Invited Lecturer

2001 The San Francisco Experience, American Hepato-Pancreato-Biliary Association, Miami Beach, FL

Invited Lecturer

2001 Liver Allocations: Why the Rules Should Change, American Society of Transplant Surgeons, Chicago, IL

Invited Lecturer

2001 Hepatic Transplantation for Malignancy, American College of Surgeons, New Orleans, LA

Invited Lecturer

2002 Pitfalls in the Spanish Organ Donor Model, University of Colorado, Breckenridge, CO

Invited Lecturer

2003 Living Donor Liver Transplantation, NATCO Transplant Institute Program, San Diego, CA

Invited Lecturer

2003 Outcomes of Whole Decease, Split Deceased, and Living Donor Liver Transplants in Pediatric Recipients, American Transplant Congress, Washington, D.C.

Invited Lecturer

2003 Organ Allocation: Where We Are 2003, Oregon Health & Sciences University Conference, Portland, OR

Invited Lecturer

2003 Living Donor Liver Transplant for Hepatocellular Carcinoma, Grand Rounds, Mayo Clinic, Rochester, MN

2003 Living Donor Liver Transplant for Hepatocellular Cancer, American Association for the Study of Liver Diseases, Boston, MA

Invited Lecturer

2003 Role of Adult Living Liver Donation in Patients with Hepatocellular Cancer, American Association for the Study of Liver Diseases, Boston, MA

Invited Lecturer

7 of 60

Prepared: December 9, 20142004 Expanded Living Donor Options for Transplant, URN

Medical Management Conference, New Orleans, LA Invited Lecturer

2005 Rationing Healthcare, Lessons from Organ Transplantation, Grand Rounds, Columbia University, New York, NY

2005 Tumor Surveillance - What can and Should be Done?, American Association for the Study of Liver Diseases, San Francisco, CA, San Francisco, CA

Invited Lecturer

2006 Managing Hepatocellular Carcinoma: Lessons Learned, Looking Ahead, American Hepato-Pancreato Biliary Association, Miami Beach, FL

Invited Lecturer

2006 Rationing in Health Care: Lessons from Transplantation, Beth Israel Deaconess Medical Center Transplant Conference, Boston, MA

Invited Lecturer

2006 Hepatocellular Carcinoma, Grand Rounds, Beth Israel Deaconess Medical Center, Boston, MA

2006 Extending Indication for HCC - Beyond the Milan Criteria, 2006 World Transplant Congress, Boston, MA

Invited Lecturer

2006 An Overview of Abdominal Organ Transplantation, United Resource Networks, Seattle, WA

Invited Lecturer

2006 Liver Transplantation: Patient Selection and Evaluation, Hospitalization to Discharge Care Issues, United Resource Networks, Seattle, WA

Invited Lecturer

2006 Managing Hepatocellular Carcinoma: Lessons Learned, Looking Ahead, American Hepato-Pancreato Biliary Association, Miami Beach, FL

Invited Lecturer

2007 Introduction: Expanding the Donor Pool, American Society of Transplant Surgeons, Marco Island, FL

Invited Lecturer

2008 Practical Knowledge for Transplant Surgeons: Academic Productivity, American Society of Transplant Surgeons, Marco Island, FL

Invited Lecturer

2008 Practical Knowledge for Transplant Surgeons: Managing a Clinical Transplant Program, American Society of Transplant Surgeons, Marco Island, FL

Invited Moderator

2008 Yesterday When I Was Young: The Changing High Risk Recipient, American Society of Transplant Surgeons, Marco Island, FL

Invited Lecturer

2008 American Society of Transplant Surgeons, Marco Island, FL a) The High Risk Recipient Debate b) A Bird in the Hand: Pediatric Kidney Live Donors vs Deceased Donors for Primary Transplant c) Won't Get Fooled Again: Liver Re-transplantation for Hepatitis C d) Risky Business: Should Transplant Outcomes be Risk Adjusted?

Invited Debate Moderator

2008 Resection and Transplantation for HCC, International Invited Speaker

8 of 60

Prepared: December 9, 2014Perspectives on Hepatic, Pancreatic and Biliary Surgery, Columbia University, New York City, NY

2008 AASLD Meet the Profession, Digestive Disease Week 2008, San Diego, CA

Invited Speaker

2008 Strategies for Increasing Transplantation: The ASTS Perspective, The Collaborative National Learning Congress, Nashville, TN

Invited Speaker

2008 DSA Leadership Plans: Vision of the Future, The Collaborative National Learning Congress, Nashville, TN

Invited Speaker

2008 Liver Transplantation for Hepatocellular Carcinoma, University of Wisconsin School of Medicine and Public Health, Madison, WI

Visiting Professor

2008 President's Address, American Society of Transplant Surgeons, 2nd annual Surgical Fellows Symposium, Kiawah Island Resort, South Carolina

ASTS President

2008 Hepatocellular Carcinoma Consensus Conference, Chicago, IL

Invited Workgroup Chair

2008 Outcomes for Expanded Criteria: Milan Criteria, Hepatocellular Carcinoma Consensus Conference, OPTN/UNOS Liver and Intestinal Organ Transplant Committees, Chicago, IL

Invited Workgroup Moderator

2009 Defining the Issue of Donor-Recipient Matching, American Society of Transplant Surgeons, Marco Island, FL

Moderator

2009 Tell Her About It: Do Recipients of High-Risk Organs Complete Informed Consent? Pro/Con, American Society of Transplant Surgeons, Marco Island, FL

Keynote Debate Presenter

2009 Liver Transplantation for Hepatocellular Carcinoma, OptumHealth Care Solutions' 10th Annual: Innovations in Transplantation and the Treatment of Complex Medical Conditions Conference, San Diego, CA

Invited Lecturer

2009 Liver Transplant is the Appropriate Surgical Therapy, City of Hope 6th Annual Multidisciplinary Treatment of Gastrointestinal Neoplasms, Kona, Hawaii

Invited Presenter

2009 Government Sponsored Health Insurance for Living Donors American Society of Transplant Surgeons, Annual Meeting, Boston, MA

Invited Speaker

2009 The Future of Liver Transplantation, American Society of Transplant Surgeons, Annual Meeting, Boston, MA

Invited Chair Moderator

2009 The Effect of the Media on Transplantation, American Society of Transplant Surgeons, Annual Meeting, Boston, MA

ASTS President

2009 Acceptable Mismatch in Europe and its Impact on Highly Sensitized Recipient Waiting Lists, American Society of Transplant Surgeons, Annual Meeting, Boston, MA

Invited Moderator

9 of 60

Prepared: December 9, 20142009 Grand Rounds, Liver Transplantation for Hepatocellular

Carcinoma, University of Virginia, Charlottesville

2009 Long-Term Management of the Liver Transplant Patient, American Society of Transplant Surgeons' 3rd Annual Fellows Symposium, Scottsdale, AZ

Invited Presenter

2010 OPTN Policy Development and Feedback from FRI/Highlights of Concepts Being Explored, OPTN/UNOS, Atlanta, GA

Invited Lecturer

2010 Strategies to Fund Short and Long-Term Living Donor Outcomes Data Collection and Analysis, Living Kidney Donor Follow-up: State-of-the-Art and Future Directions, Arlington, VA

Invited Chair Moderator

2011 Reforming Transplant Care: The Society's Perspective, ASTS State of the Art Winter Symposium, Hollywood, FL

Invited Lecturer

2011 Panel: Liver Case, ASTS State of the Art Winter Symposium, Hollywood, FL

Invited Moderator

2011 Grand Rounds Lecture, Baylor University, Dallas, TX Invited Lecturer

2012 Transplantation Conference at Massachusetts General Hospital, Boston, MA

Invited Presenter

2012 Ethical Issues in Liver Transplantation, Optum Health Advances in the Management of Oncology, Stem Cell- and Solid Organ-Transplant Patients, Scottsdale, Arizona

Invited Speaker

2012 "Regulatory Aspects of Transplant Management: UNOS, CMS and Payers," ASTS Leadership Development Program, Northwestern University Kellogg School of Management, Evanston, IL

Invited Speaker

2012 "Update on the Regulatory Alphabet CMS, OPTN, HRSA, SRTR, UNOS," UCSF Transplant Symposium 2012: Today's Realities, Tomorrow's Possibilities, San Francisco, CA

Invited Speaker

2012 "Living Donor Liver Transplantation," UCSF Transplant Symposium 2012: Today's Realities, Tomorrow's Possibilities, San Francisco, CA

Invited Speaker

2012 "The Impact of Outcomes Monitoring on Innovation and Risk in Liver Transplantation," AASLD Meeting, Boston, MA

Invited Speaker

2012 "I Do Not Believe Liver Transplantation is Appropriate for Any Patients with Alcoholic Hepatitis," AASLD Meeting, Boston, MA

Invited Speaker

2013 Margins I’ll Never Revisit. ASTS State of the Art Winter Symposium, Miami FL

Invited Speaker

2013 Kidney Margins & Mini Debates. ASTS State of the Art Winter Symposium, Miami, FL

Invited Moderator

2013 Efficiency: Keeping All the Balls in the Air. ASTS State Invited Speaker

10 of 60

Prepared: December 9, 2014of the Art Winter Symposium, Miami, FL

2013 A Web-Based Living Kidney Donor Medical Evaluation Tool. ASTS State of the Art Winter Symposium, Miami, FL

Invited Speaker

2013 "SRTR: Allocation and Program Specific Reports," ATC Meeting, Seattle, WA

Moderator

2013 "Management of Hepatocellular Carcinoma," AASLD Clinical Symposium: Digestive Disease Week, Orlando, FL

Co-Moderator

2014 "Baby Boomers and Hepatitis C," OptumHealth Education - Advances in the Management of Oncology, Stem Cell and Organ Transplant Patients Conference, San Diego, CA, April 2014

Invited Speaker

2014 "Changes in Organ Allocation and its Impact on Transplantation" UCSF Transplant Symposium 2014: Riding the Wave of Change, San Francisco, CA, Sept. 2014

Invited Speaker

2014 "Surgical Options in Pediatric Liver Disease" UCSF Transplant Symposium 2014: Riding the Wave of Change, San Francisco, CA, Sept. 2014

Invited Speaker

2014 "Future of Liver Transplantation" State of the Art Lecture, Emerging Topics in liver Disease Conference, Houston, TX, Sept. 2014

Invited Speaker

2014 "UNOS and CMS: Regulations & Compliance," ASTS 8th Annual Surgical Fellows Symposium, San Diego, CA, Oct 2014

Invited Speaker

2014 Pancreas/Immunology Case Studies, ASTS 8th Annual Surgical Fellows Symposium, San Diego, CA, Oct 2014

Invited Panelist

2014 "Stifling Innovation Regulation and Risk Mentality," AASLD The Liver Meeting, Boston, MA, Nov 2014

Invited Speaker

REGIONAL AND OTHER INVITED PRESENTATIONS

1988 Pre- and Postoperative Care of the Liver Transplant Patient, Gastroenterology Update, University of California San Francisco, San Francisco, CA

Invited Lecturer

1989 Liver Transplant update: State of the Art, San Francisco General Hospital, San Francisco, CA

Invited Lecturer

1989 Liver Transplantation, San Jose Surgical Society, San Jose, CA

Invited Lecturer

1989 Liver Transplantation, California Transplant Donor Network, Las Vegas, NV

Invited Lecturer

1990 FK506 in Liver Transplantation, University of California San Francisco, San Francisco, CA

Invited Lecturer

1990 Organ Transplantation in Review: Advances in Liver Invited Lecturer

11 of 60

Prepared: December 9, 2014Transplantation, University of California San Francisco, Fresno, CA

1990 Liver Transplantation, Asian American Health Forum Conference on Hepatitis and Liver Disease, San Francisco, CA

Invited Lecturer

1992 A Surgeon's View of TIPS, Interventional Hepatobiliary Radiology Conference, San Francisco, CA

Invited Lecturer

1992 Liver Transplantation, Delta Memorial Hospital, Antioch, CA

Invited Lecturer

1992 The Patient Driven Cadaver Waiting List: Advantages & Disadvantages, University of California San Francisco, San Francisco, CA

Invited Lecturer

1992 Controversies in Allocation, American Kidney Foundation, San Francisco, CA

Invited Lecturer

1992 New Techniques in Transplantation, Grand Rounds, University of California San Francisco, San Francisco, CA

1993 Liver Transplantation Today, Grand Rounds, University of California San Francisco, San Francisco, CA

1993 Treatment of Hepatomas with Hepatotoxins in Transplantation, Liver Center Lab Retreat, San Francisco, CA

Invited Lecturer

1993 A Surgeon's View of TIPS, Interventional Hepatobiliary Radiology Conference, San Francisco, CA

Invited Lecturer

1993 Liver Transplants, Rotary Club of Santa Cruz, Santa Cruz, CA

Invited Lecturer

1994 The Cost of an Error, Grand Rounds, University of California San Francisco, San Francisco, CA

1996 Pediatric Organ Failure: An Update for Pediatricians, University of California San Francisco, San Francisco, CA

Invited Lecturer

1996 Organ Allocation, University of Colorado Winter Transplant Symposium, San Francisco, CA

Invited Lecturer

2001 Organ Allocation, Grand Rounds, California Pacific Medical Center, San Francisco, CA

2001 Transplantation for Hepatocellular Carcinoma, University of California San Francisco, San Francisco, CA

Invited Lecturer

2002 Living Donor Liver Transplantation, Grand Rounds, University of California San Francisco, San Francisco, CA

2002 New Developments in Liver Transplantation, University of California San Francisco, San Francisco, CA

Invited Lecturer

2002 Living Donor Liver Transplantation, Excellence in Invited Lecturer

12 of 60

Prepared: December 9, 2014Surgery Case Managers' Conference, San Francisco, CA

2003 Transplantation: What's new and What's Hot, Grand Rounds, University of California San Francisco, San Francisco, CA

2004 Expanding the Number of Organs for Transplantation in the United States, Excellence in Surgery Case Managers' Conference, San Francisco, CA

Invited Lecturer

2005 Rationing of Healthcare: Lessons from Organ Transplantation, Grand Rounds, University of California San Francisco, San Francisco, CA

2005 Rationing Healthcare: Lessons from Organ Transplantation, Grand Rounds, Columbia University, New York, NY

2006 Long-term Analysis of 99 Combined Liver-Kidney Transplants Over 16 Years at a Single Center, Pacific Coast Surgical Association, San Francisco, CA

Invited Lecturer

2006 Rationing Healthcare - Lessons from the Transplant Experience, East Bay Surgical Society, Walnut Creek, CA

Invited Lecturer

2006 Rationing in Health Care: Lessons from Transplantation, Grand Rounds, St. Francis Medical Center, San Francisco, CA

2006 Hepatocellular Carcinoma: Therapeutic Options, Banner Health, Scottsdale, AZ

Invited Lecturer

2006 The UCSF Liver Transplant Program: 2006 and Beyond, University of California, San Francisco, Napa, CA

Invited Lecturer

2007 Hepatocellular Carcinoma: Revolution and Evolution, University of Nebraska Medical Center, Omaha, NE

Visiting Professor

2007 Grand Rounds, Hepatocellular Carcinoma: Revolution and Evolution, University of Alberta, Edmonton, Alberta, Canada

2007 Hepatocellular Carcinoma: Revolution and Evolution & Rationing in Health Care: Lessons from Transplantation, University of Cincinnati College of Medicine, Cincinnati, OH

Visiting Professor

2007 Liver, American Transplant Congress, Moscone West Convention Center, San Francisco, CA

Invited Lecturer

2007 Moderate Session- Liver: Split and DCD Issues, American Transplant Congress, Moscone Center Room 2018/2020, San Francisco, CA

Invited Lecturer

2007 Update on Kidney Transplantation, University of California, San Francisco Division of Transplant, Napa Valley, CA

Invited Lecturer

2007 Renal Transplantation: Current Practice to Future Invited Lecturer

13 of 60

Prepared: December 9, 2014Hopes, American Nephrology Nurses' Association (ANNA), Visalia, CA

2007 Liver Transplant 2007, UCSF, Napa, CA Invited Presenter

2008 Liver Transplant, UCSF Fresno Medical Education Program, Fresno, CA

Invited Lecturer

2008 Rationing in Health Care, UCSF Fresno Medical Education Program, Fresno, CA

Invited Lecturer

2008 Update in Transplantation at UCSF, UCSF, Napa, CA Invited Lecturer

2008 Liver Transplantation for Hepatocellular Carcinoma, University of Wisconsin School of Medicine and Public Health, Madison, WI

Invited Lecturer

2009 Controversies in Transplantation: Should we Compensate Organ Donors? UCSF, Napa, CA

Invited Lecturer

2009 State of Transplantation at UCSF, UCSF, Napa, CA Invited Lecturer

2009 Grand Rounds, William J von Liebig Transplant Center, Mayo Clinic, Rochester, MN

2010 Twenty Years of Liver Transplantation at UCSF, UCSF, Napa, CA

Invited Lecturer

2010 Left Lobe Living Donor Liver Transplantation, ATC Congress/ASTS, San Diego, CA

Workshop Co-Chair

2010 Liver Split Myself in Two: What's New, What Matters, What's Next, UCSF Transplant 2010 Postgraduate Course, San Francisco, CA

Invited Speaker

2011 Rationing of Healthcare: Lessons from Transplantation, San Francisco Surgical Society, San Francisco, CA

Invited Speaker

2011 "Surgical Treatment for Liver Malignancies," Cowan Cancer Symposium, Salt Lake City, UT

Invited Lecturer

2011 "Rationing of Healthcare: Lessons in Organ Transplantation," Harold C Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX

Invited Speaker

2012 "A New Method for Stenting the Bile Duct ," 4th UCSF/CALTECH Innovation Symposium, Caltech, Pasadena, CA

Invited Speaker

2012 "UNOS Update," CTDN All Staff Meeting, Oakland, CA Invited Speaker

2012 “Living Donor Liver Transplantation; Balancing Donor Risk and Recipient Benefit,” MacLean Center Seminar Series on Ethical Controversies in Organ Transplantation, Chicago, IL

Invited Speaker

2012 "Current Status of Deceased Donor and Live Donor Liver Transplant Program at UCSF," UCSF Liver Transplant Conference 2012, Napa, CA

Invited Speaker

2013 "Live Donor Liver Transplant - Left Versus Right Lobe," UCSF Liver Transplant Conference 2013, Napa, CA,

Invited Speaker

14 of 60

Prepared: December 9, 2014Nov. 2013

2013 "Evolution of transplantation for HCV over time and the future outlook," Gilead - HCV Liver Transplant Advisory Board, Foster City, CA, Dec. 2013

Invited Speaker

2014 "Liver Transplant from Hepatology and Surgical Perspective," Fresno Community Seminar, Fresno, CA, March 2014.

Invited Speaker

2014 "State of Transplantation at UCSF," UCSF Kidney Transplant Conference, Napa, CA, April 2014

Invited Speaker

2014 "Rationing of Health Care Using Transplantation as a Model," UCSF Department of Urology Grand Rounds, San Francisco, CA, April 2014

Invited Speaker

2014 "State of the Transplant Union for UCSF," UCSF Division of Transplantation Quarterly Staff Meeting, San Francisco, CA, Sept 2014

Invited Speaker

2014 "Liver Transplant and Hepatocellular cancer: Ablate and wait," UCSF Liver Transplant Conference 2014, Napa, CA, Nov 2014

Invited Speaker

CONTINUING EDUCATION COURSES ATTENDED2000 Massachusetts Medical Society, New England Journal of Medicine, On line peer

review

2001 Department of Surgery, Grand Rounds/Clinical Service Conference, UCSF


2002 Department of Medicine, Advisor & Teacher - Surgery 110, UCSF

2002 Transplant Mortality & Morbidity Conference, UCSF

2002 Research Publications in Peer Reviewed Journals, UCSF

2002 American Society of Transplant Surgeons, UCSF

2002 Controversies in Transplantation, UCSF

2002 American Transplant Congress, UCSF

2002 American Surgical Association Annual Meeting, UCSF

2002 Postgraduate General Surgery Conference, UCSF


2003 American Society of Transplant Surgeons, UCSF

2003 NATCO Transplant Institute Conference, UCSF

2003 American Surgical Association Annual Meeting, UCSF

2003 American Transplant Congress, UCSF

2003 Medical Education Collaborative Symposium, UCSF

2003 Oregon Health Science University Conference, UCSF

2003 Grand Rounds Presentation, Mayo Clinic, UCSF

15 of 60

Prepared: December 9, 20142003 Advances in Adult Living Donor Liver Transplantation, UCSF

2003 Advisor and Teacher - Surgery 110, UCSF

2003 Transplant Mortality & Morbidity Conference, UCSF


2004 CME Certification Program, Institute for Medical Quality, San Francisco, CA


2005 Pacific Coast Surgical Association, American College of Surgeons, Dana Point, CA

2005 Update in Transplantation, PESI Healthcare, Napa, CA

2005 Controversies in Liver Transplantation, Global Educational Group, Los Angeles, CA

2005 125th Annual American Surgical Association Meeting, Palm Beach, FL

2005 Living Donor Evaluation in Kidney Transplant Programs in the U.S., Web-based training

2006 Pacific Coast Surgical Association, American College of Surgeons, San Francisco, CA

2006 126th Annual American Surgical Association Meeting, Boston, MA

2007 7th ASTS State-Art Winter Symposium -Solving the Organ Shortage Crisis-Implications of Expanding the Donor Pool, Marco Island, FL

2007 International Liver Transplantation Society ILST 13th Annual International Congress, Rio de Janeiro, Brazil

2007 International Liver Transplantation Society ILST 13th Annual International Congress, Rio de Janeiro, Brazil

2008 American Surgical Association 124th Annual Meeting, New York, NY (17 hrs, AMA PRA) [April 24-26, 2008]

2008 UCSF Update in Kidney Transplantation, Napa, CA (7 hrs, AMEDCO) [May 2-3, 2008]

2008 Organ Donation and Transplantation Breakthrough Collaborative Transplant Growth & Mgmt Collaborative: 4th Annual Nat'l Congress , Nashville, TN (8.25 hrs) [October 23-24, 2008]

2008 Massachusetts Medical Society, New England Journal of Medicine, On line peer review (1 hr, AMA PRA) [July 1-Dec 30, 2008]

2008 MGR09072 Highly Reliable Surgical Team Training, UCSF (4 hrs, AMA PRA) [Nov 3-18, 2008]

2008 Department of Surgery, Grand Rounds/Clinical Service Conference, UCSF (20 hrs) [July 2008 - June 2009]

2008 Massachusetts Medical Society, New England Journal of Medicine, On line peer review

2009 ASTS 9th Annual State of the Art Winter Symposium - The Right Organ for the Right Recipient, Marco Island, FL (16 hrs) [January 16-18, 2009]

2009 City of Hope - 6th Annual Conference on Advances in the Multidisciplinary Treatment of Gastrointestinal Neoplasms, Kona, HI (16 hrs ACCME) [February 26-28, 2009]

2009 UCSF Department of Surgery Grand Rounds, San Francisco, CA (7 credits) (Jul-Dec

16 of 60

Prepared: December 9, 20142009)

2009 Liver Transplantation Symposium, Royal Hospital, Sultanate of Oman Ministry of Health (5 hrs) [March 26, 2009]

2009 Transplant Immunosuppression: Today's Issues, University of Minnesota, Minneapolis, MN. (8 credits) (Sept. 23-26, 2009)

2009 2009 American Transplant Congress-Physicians, Boston, MA (20 hours, ACCME) [May 30-June 3, 2009]

2009 ILTS - 15th Annual International Congress, New York City, NY (14 hrs, IAHB-AMEDCO) [July 8-11, 2009]

2009 Archives of Surgery manuscript review (3 hrs, AMA Continuing Physician Professional Development, AMA PRA) [December 7, 2009]

2010 ASTS 10th Annual State of the Art Winter Symposium: The Cutting Edge of Transplant Surgery, Fort Lauderdale, FL (20 hrs, ACCME) [January 14-17, 2010]

2010 UCSF School of Medicine, Department of Surgery Grand Rounds, San Francisco, CA (12 hrs, ACCME) [January-June 2010]

2010 American Transplant Congress Meeting, San Diego, CA (20 hrs, The Institute for the Advancement of Human Behavior and AMEDCO) [May 1-5, 2010]

2010 UCSF School of Medicine, Department of Surgery Grand Rounds, San Francisco, CA (14 hrs, ACCME) [Jul2010-Dec 2010]

2010 UCSF Postgraduate Course: What's New, What Matters, What's Next: UCSF Transplant 2010, San Francisco, CA (13.75 hrs), ACCCME-AMA PRA) [September 22-24, 2010]

2010 The American Association for the Study of Liver Diseases 61st Annual Liver Meeting, Boston, MA

2010 ILTS – 16th Annual International Congress, Hong Kong, China (14 hrs, The Institute for Advancement of Human Behavior and AMEDCO) [June 13-19, 2010]

2010 UCSF - 2010 Update in Liver Transplantation, Silverado, Napa, CA (4 hrs, AMEDCO) [November 12-13, 2010]

2011 UCSF Department of Surgery Grand Rounds, San Francisco, CA (18 hrs) [Jan-June 2011]

2011 Anesthesia and Surgery: Joint Ventures in Clinical Excellence, San Francisco, CA, UCSF School of Medicine AMA PRA Category 1 (6.75) [February 5, 2011]

2011 American Transplant Congress Meeting- Physicians & Transplant Coordinators, Philadelphia, PA (19 hrs, AMA PRA) [April 30-May 4, 2011]

2011 ILTS - 2011 Joint International Congress of ILTS, ELITA & LICSAGE, Valencia Spain (23 hrs) [June 22-25, 2011]

2011 UCSF Department of Surgery Grand Rounds, San Francisco, CA (8 hrs) (July-Dec 2011)

2012 UCSF Department of Surgery Grand Rounds, San Francisco, CA (14 credits) (Jan-Jun 2012)

2012 ASTS 12th Annual State of the Art Winter Symposium: Surgical Challenges, Creative Solutions, Miami, FL (4 hrs, AMA PRA Category 1 [January 12-15, 2012]

2012 AHPBA Sponsored Consensus Conference on the Multidisciplinary Treatment of

17 of 60

Prepared: December 9, 2014Colorectal Cancer Liver Metastases, San Francisco, CA (6 hrs, AMA PRA Category 1, Univ of Texas MD Anderson Cancer Center [January 18, 2012]

2012 American Surgical Association, 132nd Annual Meeting, San Francisco, CA 3 hrs, AMA PRA Category 1, American College of Surgeons [April 26-28, 2012]

2012 The Harvard Medical School, Transplantation Conference, Boston, MA, 2.0 hrs, AMA PRA Category 1, ACCME Harvard Medical School [June 30, 2012]

2012 Manuscript Review for New England Journal of Medicine CME Program, 2.0 hrs, AMA PRA Category 1, Massachusetts Medical Society [Jan 1 2012 - June 30 2012]

2012 UCSF Department of Surgery Grand Rounds, San Francisco, CA (10 credits) (July-Dec 2012)

2013 ASTS 13th Annual State of the Art Winter Symposium, January 31-February 3, 2013, Miami, FL (3 Credits)

2013 UCSF Department of Surgery Grand Rounds, San Francisco, CA (15 credits, Jan-Jun 2013 )

2013 UCSF Department of Surgery Grand Rounds, San Francisco, CA (14 credits, Jul-Dec 2013)

2014 UCSF Department of Surgery Grand Rounds, San Francisco, CA (14 credits, Jan-Jun 2014)

GOVERNMENT AND OTHER PROFESSIONAL SERVICE

1988 - 1995 Board of Directors, California Transplant Donor Network

Member

1988 - 2008 Medical Affairs Committee, California Transplant Donor Network

Committee Member

1990 - 1994 Organ Procurement Committee, United Network for Organ Sharing

Committee Member

1993 - 1995 Liver Committee, United Network for Organ Sharing

Committee Chair

1994 - 1995 Renal Subcommittee, California Transplant Donor Network

Committee Member

1994 - 1996 Computer Modeling Oversight Committee, United Network for Organ Sharing

Committee Member

1994 - 1997 California Transplant Donor Network Medical Director

1994 - 1999 Travelers Insurance Companies Member, Advisory Board

1996 - 1999 CenterSpan Member, Board of Directors

1999 - 1999 Department of Health and Human Services Member, Expert Review Panel

1999 - 2003 Scientific Advisory Committee, United Network for Organ Sharing

Committee Chair

2004 - 2004 National Institutes of Health Member, Action Plan for Liver Disease Research

18 of 60

Prepared: December 9, 2014Working Group

2004 - 2005 Data Working Group, United Network for Organ Sharing

Committee Member

2008 - 2008 Legislative Briefing to Increase Donation Rates, Congressman Costa, Sacramento, CA

President Advisor, ASTS

2009 - 2009 Legislative Briefing, House and Senate Leadership, Congressman Costa

President Advisor, ASTS


Member

2010 - 2010 Presentation at State Capitol, State Assembly, Insurance Coverage for Post-Transplant Medications, Sacramento, CA

Past President Advisor, ASTS

2010 - 2011 Medical/Scientific Representative, United Network for Organ Sharing

Board of Directors


Chair Elect

2011 - 2012 Organ Procurement and Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS)

Vice President

2011 - 2012 Organ Procurement and Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS) Membership and Professional Standards Committee (MPSC)

Chair


Chair

2012 - 2013 Organ Procurement and Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS)

President

2013 - 2015 United Network for Organ Sharing At Large Member, Liver and Intestinal Organ Transplantation Committee

UNIVERSITY AND PUBLIC SERVICEUNIVERSITY SERVICEUCSF CAMPUS-WIDE 1988 - present Academic Senate Member

1992 - 1998 Committee on Interdisciplinary Practices Member

1994 - 1994 Academic Senate, Ad Hoc Committee Review No 93-163

Member

2001 - 2001 Academic Senate, Ad Hoc Committee Review No 2000-72

Member

19 of 60

Prepared: December 9, 2014 - IT Governance Steering Committee Member

SCHOOL OF MEDICINE

1988 - 2006 Physician/Nurse Liaison Committee Member

1989 - 2002 Surgical Case and Hospital Mortality Review Committee

Member

1990 - 2000 Infection Control Committee Member

1990 - present Antibiotic Subcommittee of Pharmacy and Therapeutics

Member

1995 - 2000 Outcomes Advisory Board for the Clinical Enterprise

Member

1998 - 2002 Committee on Human Research Member

2002 - present IT Steering Committee Chairperson

2003 - present IT Infrastructure Subcommittee Member

2006 - present Ad Hoc Tissue Committee Member

2006 - present Tissue Committee of the Medical Staff Member

2006 - 2007 Heathcare Technology Assessment Program Committee

Member

2007 - present Moffitt Liver Cancer Tumor Board Member

2007 - present IT Clinical Enterprise Subcommittee Member

DEPARTMENTAL SERVICE

1988 - present Multi-disciplinary Kidney Transplantation Selection Committee

Member

1988 - present Fellowship Selection Committee Member

1988 - present Multi-disciplinary Transplantation Liver Selection Committee

Member

1989 - present Education Committee Member

1990 - 1998 Quality Assurance Committee Member

1994 - 1994 Search Committee, Chief of Vascular Surgery Member

1995 - 1995 Ad Hoc Committee Review No 95-12 Member

1996 - 2006 Perioperative Efficiency Committee Member

1998 - 2000 Transplant Service Line Integration Team Member

2000 - 2000 Ad Hoc Committee Review No 99-123 Member

2003 - present Contracting Committee Member

2004 - present Surgery IT Steering Committee Chairperson

2004 - present Merit and Promotions Committee Chairperson

2006 - 2008 Management of Myelomeningocele Study (MOMS) Oversight Committee

Member

20 of 60

Prepared: December 9, 20142006 - 2008 Search Committee, Chief of Vascular Surgery Member

2007 - 2008 Package Desk Allocation Task Force Member

2007 - present Multidisciplinary Team Discharge Planning Committee

Member

2007 - present Transfer Center Committee Member

2007 - present Multidisciplinary Discharge Planning Kidney Task Force

Member

2007 - present Multidisciplinary Discharge Planning Liver Task Force

Member

2008 - present Transplant Quality Improvement Committee Member

2008 - present Transplant Hepatology Steering Committee Member

PUBLIC SERVICE

2007 - 2010 American Liver Foundation Chair, Medical Advisory Board

2007 - 2008 California Transplant Donor Network, Monthly Utilization Review Committee

Member

2007 - 2007 United Network for Organ Sharing, Living Donor Task Force

Member

2008 - present California Transplant Donor Network Member, Board of Directors

SUMMARY OF SERVICE ACTIVITIES

My service activities are mainly focused on the care of the transplant patient. At the hospital and interdisciplinary levels, I have taken a leadership role in the complex issues related to administration of the largest abdominal transplant service in the United States, if not in the world. I have concentrated my expertise on selection of the ideal patients for transplantation, quality assurance, perioperative efficiency, service line integration, billing and contracting, appropriate transfer and discharge of our organ transplant patients, and working with our hepatology and nephrology physicians in an integrated fashion to provide optimal patient care.

At the Department/division level my major goals have been to provide mentorship for the transplant faculty, both in clinical and non-clinical areas. I have provided direction and support for research focus for each of the faculty. Currently, the Division has the most NIH funding of any Division in the Department of Surgery. The clinical activity of the Division has been outstanding, both in terms of quality and quantity. I also head the Merit and Promotions Committee and have participated in key search committees for Department chairs.

On a more global basis, I've worked with the California Transplant Donor Network as a Board member to improve organ donation, UNOS/OPTN as a board member, and then President to improve organ donation and allocation within the United States, and I've worked with advising state legislators and national legislative bodies regarding concern for recipient insurance

21 of 60

Prepared: December 9, 2014coverage for post-transplant medication. As a result of this testimony, AB2352 passed, extending the immunosuppressive drug coverage through MediCal for one additional year.

TEACHING AND MENTORINGTEACHINGFORMAL SCHEDULED CLASSES FOR UCSF STUDENTS

Qtr Academic Yr Course Number and Title Teaching

Contribution Units Class Size

F W Sp Su

1988 - present

Surgery 110, Surgery Core Clerkship Lecture: Clinical Management of Fluid and Electrolytes

12 8

F W Sp Su

1988 - present

Surgery 140.18, Advanced Transplant Surgery (Liver Transplantation)

Instructor 6 1

F W Sp Su

1988 - present

Surgery 150.01, Research in Surgery Instructor: Supervision of residents/medical students in their research year

6 3

F W Sp Su

- present Surgery 160.07, Surgery Donor Runs Instructor

F W Sp Su

- present Surgery 160.08, The Organ Transplant Experience

Instructor

F W Sp Su

1988 - present

Surgery 400, General Surgery Staff Conference

Instructor: Periodic lecture at grand rounds and clinical services conference, monthly Multidisciplinary Transplantation Conference

1 0

F W Sp Su

1988 - present

Surgery 450, Clinical Surgery Instructor: Informal teaching in the OR

1 1

F W Sp Su

1989 - 1994 Surgery 110, Surgery Core Clerkship Site Director 12 8

POSTGRADUATE AND OTHER COURSES

1988 - 1988 Continuing Education, Department of Surgery, UCSF

Lecturer, 2 lectures)

1996 - 1996 Fresno, Office of Postgraduate Education, UCSF

Lecturer

1996 - 1996 Department of Pediatrics Update, UCSF Lecturer

22 of 60

Prepared: December 9, 20142001 - 2001 Continuing Education, Department of

Surgery, UCSFLecturer

2002 - 2002 Continuing Education, Department of Surgery, UCSF

Lecturer

2008 - 2008 MGR09072 Highly Reliable Surgical Team Training, UCSF School of Medicine

Lecturer

2009 - 2009 6th Annual conference on Advances in the Multidisciplinary Treatment of Gastrointestinal Neoplasms, City of Hope [Hawaii]

Lecturer

2009 - 2009 Liver Transplantation Symposium, Sultanate of Oman Ministry of Health Royal Hospital

Lecturer

2010 - 2010 UCSF Postgraduate Course, What's New, What Matters, what's Next: UCSF Transplant 2010, San Francisco, CA

Moderator and Lecturer

2012 - 2012 UCSF Postgraduate Course: Today's Realities, Tomorrow's Possibilities, Transplant Symposium 2012, San Francisco, CA

Lecturer

1990 - 2013 Update on Liver Transplantation, Napa, CA (Annual UCSF Postgraduate Course)

Lecturer

1990 - 2014 Update on Kidney Transplant, Napa, CA (Annual UCSF Postgraduate Course)

Lecturer

TEACHING NARRATIVE

My teaching responsibilities are directed toward medical students, residents, fellows and junior faculty.

For the medical students I have taught a class for 26 years on the clinical management of fluid and electrolytes. This small session class has received praise from the students. In addition, the medical students rotate on the transplant services where I am involved in their ward teaching. I have also mentored senior students in research projects.

For the residents and fellows, I provide teaching in the operating room and on the ward.

As a transplantation surgeon in a complex field, I have been assisting my faculty in both their clinical and research efforts. This has included helping them further new operative techniques and providing advice regarding clinical issues. I have been assisting the junior faculty in obtaining NIH funding, placing them in key situations on the national transplantation scene, and at the same time giving them time to take advantage of the opportunities.

23 of 60

Prepared: December 9, 2014MENTORINGPREDOCTORAL STUDENTS SUPERVISED OR MENTORED

Dates Name Program or School Role Current Position2000 - 2000 Elika Kashef University of

California, San Francisco

Research Advisor Registrar, Radiology London England

2002 - 2002 David Finley University of California, San Francisco

Research Advisor Resident in Urology

2004 - 2004 Merisa Piper University of California, San Francisco

Research Advisor Staff Research Associate, University of California, San Francisco

2005 - 2005 Stephanie Chang


Research Advisor Medical Student, University of California, San Francisco

2005 - 2005 Michael Farr University of California, San Francisco

Research Advisor Student, University of California, Santa Barbara

2009 - 2011 Aida Martinez

University of San Francisco

Mentor, Research Advisor

Biology Major, USF, San Francisco

POSTDOCTORAL FELLOWS AND RESIDENTS DIRECTLY SUPERVISED OR MENTORED

Dates Name Fellow Faculty Role Current Position

1988 - 1990 John McVicar, M.D.


Clinical Training Associate Professor, University of California, Davis

1989 - 1991 John Rabkin, M.D.


Clinical Training Clinical practice, California Pacific Medical Center

1989 - 1992 Chris Freise, M.D.


Research Training Professor, University of California, San Francisco

1990 - 1992 Peter Stock, M.D.


Clinical Training Professor, University of California, San Francisco

1991 - 1992 Matt Reed, M.D.


Research Training Clinical Practice

1991 - 1993 Ginny Bumgardner, M.D., Ph.D.


Clinical Training Professor, Ohio State University

1992 - 1993 Michael McMullen, M.D.


Research Training Clinical Practice

1992 - 1994 Susan Orloff, M.D.


Clinical Training Associate Professor, University of Oregon HSC

1992 - 1994 Lisa Florence, M.D.


Clinical Training Clinical Practice, Swedish Medical Center, Organ Transplant Program

24 of 60

Prepared: December 9, 2014


1993 - 1995 Michael Wachs, M.D.


Clinical Training Associate Professor, University of Colorado HSC

1993 - 1996 Henry Randall, M.D.


Research Training Director, Abdominal Transplantation, Hepatobiliary and Pancreatic Surgery, Saint Luke's Hospital, Kansas City, MO

1994 - 1996 Chris Freise, M.D.



1995 - 1997 Robert Osorio, M.D.


Clinical Training Clinical Practice, California Pacific Medical Center

1996 - 1997 Shunji Narumi, M.D., Ph.D.


Clinical Training Assistant Professor, Hirosaki University School of Medicine

1996 - 1998 Sandy Feng, M.D., Ph.D.



1997 - 1999 Ryutaro Hirose, M.D.


Clinical Training Associate Professor, University of California, San Francisco

1998 - 2000 Henry Randall, M.D.


Clinical Training Clinical Practice, Baylor University Medical Center

1999 - 2001 Sang-Mo Kang, M.D.



2000 - 2000 George Chang, M.D.


Research Training Assistant Professor, M.D. Anderson Cancer Center

2000 - 2002 Anthony Savo, M.D.


Clinical Training Pediatric Surgical Fellow, Children's Hospital of Wisconsin, Milwaukee, WI

2001 - 2002 Andrew Posselt, M.D.



2001 - 2003 Jeff Halldorson, M.D.


Clinical Training Associate Professor, University of Washington Medical Center

2002 - 2004 Gerry Lipshutz, M.D.


Clinical Training Assistant Professor, University of California, Los Angeles

2003 - 2005 Christopher Barry, M.D.


Clinical Training Assistant Professor, University of California, San Diego

2003 - 2005 Harish Mahanty, M.D.


Clinical Training Clinical Practice, California Pacific Medical Center

2004 - 2006 Marc University of Clinical Training Assistant Professor,

25 of 60



Melcher, M.D.

California, San Francisco

Stanford Medical Center

2005 - 2006 Andries Braat, M.D.


Clinical Training Assistant Professor, Leiden University Medical Center, Netherlands

2005 - 2006 Scott Biggins, M.D.


Research Advisor Assistant Professor of Medicine, University of Colorado, Denver

2005 - 2007 Erik Finger, M.D.


Clinical Training Assistant Clinical Professor, University of Minnesota

2005 - present

Mehdi Tavakol, M.D.


Research Advisor Research Specialist, University of California, San Francisco

2006 - 2008 Kayvan Roayaie, M.D., Ph.D.


Clinical Training Assistant Clinical Professor, Oregon Health Sciences University, Portland, OR

2007 - 2009 Matthew Levine, M.D., Ph.D.


Clinical Training Assistant Clinical Professor, University of Pennsylvania School of Medicine

2007 - 2009 Todd Brennan, M.D.


Clinical Training Assistant Clinical Professor, Duke University School of Medicine

2008 - 2010 Bruce Gelb, M.D.


Clinical Training Assistant Clinical Professor, New York University School of Medicine

2009 - 2010 Ingo Klein, M.D.


Clinical Training Assistant Clinical Professor of Surgery, Wuerzburg University, Germany

2009 - 2011 Parsia Vagefi, M.D.


Clinical Training and Research Mentor

Assistant Clinical Professor of Surgery, Harvard Medical School and Mass General Hospital

2010 - 2012 Mark Hobeika, M.D.


Clinical Training Assistant Professor, University of Texas Health Sciences, Houston, TX

2011 - 2013 Damanpreet Bedi, M.D.


Clinical Training Assistant Professor, Beaumont, Royal Oak, MI

2011 - 2013 Gregory Veillette, M.D.


Clinical Training Assistant Professor, Westchester Medical Center, Valhalla, NY

2012 - 2014 Garrett Roll, M.D.


Clinical Training Consultant in Liver Transplant Surgery and Multiorgan Procurement,

26 of 60



Queen Elizabeth Hospital,Birmingham, UK

2013 - 2015 Justin Parekh, M.D.


Clinical Training Fellow

2013 - 2015 Aaron Ahearn, M.D., Ph.D.



2014 - 2016 Amit Javed, M.B.B.S, M.S., M.Ch.



FACULTY MENTORING

Dates Name Position While Mentored Mentoring Role Current Position

1992 - present

Peter Stock, M.D., Ph.D.

Attending on Transplant Staff

Clinical and Research Mentor

Professor of Surgery, UCSF

1996 - present

Chris Freise, M.D.




1998 - present

Sandy Feng, M.D., Ph.D.




1999 - present

Ryo Hirose, M.D.



Professor of Clinical Surgery, UCSF

2001 - present

Sang-Mo Kang, M.D.



Associate Professor of Surgery, UCSF

2002 - present

Andrew Posselt, M.D., Ph.D.



Associate Professor of Surgery, UCSF

1999 - present

Francis Yao, M.D.

Attending on Hepatology Staff

Clinical and Research Collaboration

Professor of Medicine, Director of Liver Transplantation

2002 - present

Norah Terrault, M.D.

Attending on Hepatology Staff

Clinical and Research Collaboration

Professor of Medicine

MENTORING NARRATIVE

I have mentored medical students, residents, and fellows. Most recently, I mentored Mariya Samoylov, a University of California San Francisco medical student. We collaborated on studies of hepatocellular carcinoma in patients awaiting liver transplantation. Mariya was the first author on a paper recently published in the journal Liver Transplantation and we are waiting editorial decision on our recently submitted revisions to a second paper. In addition providing guidance and her research, I have also provided guidance and her career choices.

I have mentored many of the transplant fellows here at University of California San Francisco. Our senior fellow, Garrett Roll, collaborated with me on several papers that have either been published or submitted. I also helped Garrett with his surgery post fellowship position and help him find the position in Birmingham England.

27 of 60

Prepared: December 9, 2014TEACHING AND MENTORING AIDS

Roberts JP, Tomlanovich S, Del Grosso S, Torres AM. "Kidney Transplantation." UCSF Kidney Transplant Evaluation Presentation for Prospective Transplant Patients [CD-ROM]. Spanish and English Versions. Documents, Media and Mail, UCSF, San Francisco, CA: 2007.

Roberts JP. Options for Liver Transplantation. UCSF Liver Transplant Program [CD-ROM]. English and Spanish Version. 3rd Light Digital Media, LLC, San Francisco, CA: 2008.

Roberts JP, Posselt AP. Liver and Small Bowel Transplant Clinical Manual. Abdominal Transplant Program, UCSF. [Clinical Manual used by residents, fellows, nurses, on transplant floor, UCSF Medical Center. Published annually since 2008.

TEACHING AND MENTORING AWARDS AND NOMINATIONS

1991 Chief Resident Teaching Award

1992 Chief Resident Teaching Award

2005 Exceptional Physician Award

SUMMARY OF TEACHING AND MENTORING HOURS

2013 - 2014 462 total hours of teaching (including preparation)

Formal class or course teaching hours: 12 hours

Informal class or course teaching hours: 450 hours

Mentoring hours: 50 hours

Other hours:





Other hours:



28 of 60




Other hours:

RESEARCH AND CREATIVE ACTIVITIESRESEARCH AWARDSCURRENT

R38OT22183-01-00 (Co-Principal Investigator)2011 - 2014

HRSA $516,423 direct/yr1

The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes -- A Randomized Controlled Trial from the Region 5 Donor Management Goals Workgroup.

$2,001,108 total

N01 AI15416 ITN Project (Co-Investigator)2005 - 2014

NIH - NIAID $192,017 direct/yr1

Project 030ST: Immunosuppression Withdrawal in Transplantation.

$958,913 total

N01 AI15416 ITN Project (Co-Investigator)2006 - 2014


Project 029ST: Immunosuppression Withdrawal for Stable Pediatric Living Donor Liver Transplant Recipients.

$792,030 total

PAST

Liver Transplant Database (Co-Principal Investigator) 1988 - 03

N.I.H. $90,058 direct/yr1

Liver Transplant Database

MYCS 2646 (Principal Investigator) 1997 - 01

29 of 60


Roche $90,009 direct/yr1

A randomized, double-blind comparative study of the efficacy and safety of intravenous mycophenolate mofetil and azathioprine, each in combination with cyclosporine and corticosteroids in liver transplant recipients.

RADB158 (Principal Investigator) 1998 - 00

Novartis Pharmaceuticals

A one-year multicenter, randomized, placebo-RAD 158 controlled, double-blind, parallel group, dose-finding study to evaluate the safety, tolerability and pharmacokinetics of SDZ RAD in DeNovo liver transplant recipients.

$8,966 total

OLN 457 (Principal Investigator) 1998 - 99

Novartis Pharmaceuticals

A multicenter, randomized, open-label trial of Neoral versus Prograf as primary immunosuppressive therapy in subjects undergoing liver transplantation for cirrhosis due to Hepatitis C.

$27,914 total

411-98-H (Principal Investigator) 1999 - 1999

Matrix Pharmaceuticals $5,652 direct/yr1

Historical review of select patients with primary hepatocellular carcinoma.

U01 DK062500-02 (Co-Principal Investigator) 2002 - 09

NIH/NIDDK $1,025,482 direct/yr1

Biliary Atresia Clinical Research Consortium

02-01-L (Principal Investigator) 2002 - 06

Baylor Research $159,500 direct/yr1

Baylor HepC3

0468H1-313-UC (Principal Investigator) 2003 - 04

30 of 60


Wyeth-Ayerst $24,159 direct/yr1

Randomized open-label, comp eval of conversion from calcineurin inhibitor treatment (tx) to Sirolimus tx vs. continued calcineurin inhibitor tx in liver allograft recipients undergoing maintenance therapy

002 6/04 (Principal Investigator) 2003 - 04

Fujisawa Healthcare $3,320 direct/yr1

A retrospective analysis of the ten-year patient outcomes from the randomized, multi-center trial comparing the use of Prograf and Cyclosporine in primary liver transplant

N01 AI15416 ITN Project 024ST (Co-Principal Investigator)

2004 - 09

NIH $158,567 direct/yr1

Project 024ST Feng (Site PI): Immune Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients. A phase II multicenter trial to assess safety and efficacy of campath-1H and tacrolimus followed by immunosuppression withdrawal in liver transplantation.

$771,294 total

ML 18423 (Principal Investigator) 2005 - 08

Roche Labs $50,021 direct/yr1

Liver Spare the Nephron (STN) Study $100,041 total

COLO400A2426 (Principal Investigator) 2005 - 09

Novartis Pharmaceuticals $33,295 direct/yr1

Randomized evaluation of fibrosis due to hepatitis C after de novo liver transplant.

$110,984 total

ADS-TCAD-P0206 (Principal Investigator) 2009 - 2010

Adamas $193,788.10 direct/yr1

A Randomized Open Label Study Comparing the Efficacy, Safety and Tolerability of Oral Administration of

$244,173 total

31 of 60


Amantadine and Ribavirin with Oseltamivir Versus Oseltamivir to Influenza A Virus Infected Immunocompromised Subjects

5R21 DK078702-02 (Co-Principal Investigator) 2009 - 2011

NIH -- NIH $150,000 direct/yr1

Effect of Obesity on Long-term Clinical Outcomes after Kidney Transplant.

$275,000 total

5501-G000-202 (Co-Principal Investigator) 2010 - 2011

Eisai Global Clinical Development $114,302.95 direct/yr1

A Phase 2, Randomized, Multicenter, Placebo-controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy, Safety, and Population Pharmacokinetics of Once-Daily Oral E5501 Tablets Used Up to 7 Days in Subjects with Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures.

$288,043.42 total

AEB071 B2201 (Principal Investigator) 2010 - 2012

Novartis Pharmaceuticals Corporation $120,456 direct/yr1

A 24-month Randomized, Multicenter Study, Evaluating Efficacy, Safety, Tolerability and Pharmacokinetics of Sotrastaurin (STN) combined with Tacrolimus (TAC) vs. a Tacrolimus/Mycophenolate Mofetil (MMF) based control regimen in de novo liver transplant recipients.

$274,781 total

5501-G000-202 (Co-Investigator) 2010 - 2012Eisai Global Clinical Development

Industry Sponsored Clinical Trial $114,302.95 direct/yr1

A Phase 2, Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy, Safety, and Population Pharmacokinetics of Once-Daily Oral E5501 Tablets Used Up to 7 Days in Subjects with Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures.

Pilot Research Award (Co-Investigator) 01/01/2012 - 12/31/2012

32 of 60


REAC Pilot $30,000 direct/yr1

Factors Limiting the Number of Live Kidney Donations

NO1 AI15416 ITN Project (Co-Investigator) 2005 - 2012


Project 024ST: Immune System Suppression with Alemtuzumab and Tacrolimus in Liver Transplantation Patients.

$771,294 total

PEER REVIEWED PUBLICATIONS

33 of 60


1. Roberts JP, Saik RP. Cimetidine for prevention of acute gastrointestinal bleeding. N Engl J Med, Jul/10/1980;303(2):109-10.

2. Roberts JP, Perry MO, Hariri RJ, Shires GT. Incomplete recovery of muscle cell function following partial but not complete ischemia. Circ Shock, 1985;17(3):253-8.

3. Roberts JP, Roberts JD, Skinner C, Shires GT, Illner H, Canizaro PC, Shires GT. Extracellular fluid deficit following operation and its correction with Ringer's lactate. A reassessment. Ann Surg, Jul/1985;202(1):1-8.

4. Hariri RJ, Supra EL, Roberts JP, Lavyne MH. Effect of naloxone on cerebral perfusion and cardiac performance during experimental cerebral ischemia. J Neurosurg, May/1986;64(5):780-6.

5. Chiao JJ, Roberts JP, Illner HP, Shires GT. Permeability of red-cell membrane to adenosine triphosphate (ATP) molecules during hemorrhagic shock. Surgery, Sep/1987;102(3):528-33.

6. Fantini GA, Roberts JP, Lowry SF, Albert JD, Tracey KJ, Legaspi A, Minei JP, Chiao J, Shires GT. Effect of hormonal and substrate backgrounds on cell membrane function in normal males. J Appl Physiol, Sep/1987;63(3):1107-13.

7. Legaspi A, Roberts JP, Horowitz GD, Albert JD, Tracey KJ, Shires GT, Lowry SF. Effect of starvation and total parenteral nutrition on electrolyte homeostasis in normal man. JPEN J Parenter Enteral Nutr, 3/1988;12(2):109-15.

8. Legaspi A, Roberts JP, Albert JD, Tracey KJ, Shires GT, Lowry SF. The effect of starvation and total parenteral nutrition on skeletal muscle amino acid content and membrane potential difference in normal man. Surg Gynecol Obstet, Mar/1988;166(3):233-40.

9. Michals M, Roberts JP, Canafax D. Hearing loss associated with muromonab-CD3 therapy. Clin Pharm, Dec/1988;7(12):867-8.

10. Roberts JP, Forsmark C, Lake JR, Ascher NL. Liver transplantation today. Annu Rev Med, 1989;40:287-303.

11. Ross, BD, Roberts, JP, Tropp, J, Derby, K, Bass, N, and Hawryszko, C. Phosphorus imaging of brain in HE. Magnetic Resonance Imaging, 1989;7:82.

12. Letourneau JG, Hunter DW, Ascher NL, Roberts JP, Payne WD, Thompson WM, Najarian JS, Castaneda-Zuniga WR, Day DL. Biliary complications after liver transplantation in children. Radiology, Mar/1989;170(3 Pt 2):1095-9.

13. Roberts JP, Shackford S, Peters RM. Metabolism of D lactate in patients receiving hypertonic sodium lactate solution. Surg Gynecol Obstet, May/1989;168(5):429-32.

14. Roberts JP, Debas HT. A simplified technique for rapid truncal vagotomy. Surg Gynecol Obstet, Jun/1989;168(6):539-41.

15. Roberts JP, Ascher NL, Fryd DS, Hunter DW, Dunn DL, Payne WD, Sutherland DE, Castaneda-Zuniga W, Najarian JS. Transplant renal artery stenosis. Transplantation, Oct/1989;48(4):580-3.

16. Prager MC, Gregory GA, Ascher NL, Roberts JP. Massive venous air embolism during orthotopic liver transplantation. Anesthesiology, Jan/1990;72(1):198-200.

34 of 60

Prepared: December 9, 201417. Ostroff JW, Roberts JP, Gordon RL, Ring EJ, Ascher NL. The management of T tube leaks in orthotopic liver transplant recipients with endoscopically placed nasobiliary catheters. Transplantation, May/1990;49(5):922-4.

18. Pinson CW, Daya MR, Benner KG, Norton RL, Deveney KE, Ascher NL, Roberts JP, Lake JR, Kurkchubasche AG, Ragsdale JW. Liver transplantation for severe Amanita phalloides mushroom poisoning. Am J Surg, May/1990;159(5):493-9.

19. Krams SM, Van de Water J, Coppel RL, Esquivel C, Roberts J, Ansari A, Gershwin ME. Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis. Hepatology, Aug/1990;12(2):306-13.

20. Roberts JP, Hughes L, Goldstone J, Ascher NL. Examination of vascular anastomoses during liver transplantation by intraoperative Doppler duplex scanning. Clin Transplant, Aug/1990;4(4):206-9.

21. Olcott EW, Ring EJ, Roberts JP, Ascher NL, Lake JR, Gordon RL. Percutaneous transhepatic portal vein angioplasty and stent placement after liver transplantation: early experience. J Vasc Interv Radiol, Nov/1990;1(1):17-22.

22. Sterneck, M, Ferrell, L, Ascher, NL, Roberts, JP, and Lake, J. Mycobacterial infection after liver transplantation: a report of three cases and review of the literature. Clin Transpl, 1991;6:55.

23. Lidofsky, SD, Lake, JR, Roberts, JP, and Ascher, NL. Approach to the management of fulminant hepatic failure Transplantation and Immunology, 1991;7(3):3-6.

24. Cohen N, Gumbert M, Birnbaum J, Lim VL, Falco D, Ascher N, Roberts J, Garovoy MR. An improved method for the detection of soluble interleukin 2 receptors in liver transplant recipients by flow cytometry. Transplantation, Feb/1991;51(2):417-21.

25. Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, Zeldis JB, Ascher NL, Roberts J, Wright TL. Hepatitis C in patients undergoing liver transplantation. Ann Intern Med, Feb/15/1991;114(4):282-4.

26. Aldape KD, Fox HS, Roberts JP, Ascher NL, Lake JR, Rowley HA. Cladosporium trichoides cerebral phaeohyphomycosis in a liver transplant recipient. Report of a case. Am J Clin Pathol, Apr/1991;95(4):499-502.

27. Roberts JP, Ring E, Lake JR, Sterneck M, Ascher NL. Intrahepatic portocaval shunt for variceal hemorrhage prior to liver transplantation. Transplantation, Jul/1991;52(1):160-2.

28. Wright TL, Hsu H, Donegan E, Feinstone S, Greenberg H, Read A, Ascher NL, Roberts JP, Lake JR. Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med, Jul/15/1991;115(2):111-2.

29. Freise CE, Clemmings S, Clemens LE, Alan T, Ashby T, Ashby E, Burke EC, Roberts JP, Ascher NL. Demonstration of local immunosuppression with methylprednisolone in the sponge matrix allograft model. Transplantation, Aug/1991;52(2):318-25.

30. Roberts JP, Ascher NL, Lake J, Capper J, Purohit S, Garovoy M, Lynch R, Ferrell L, Wright T. Graft vs. host disease after liver transplantation in humans: a report of four cases. Hepatology, Aug/1991;14(2):274-81.

31. LaBerge JM, Ferrell LD, Ring EJ, Gordon RL, Lake JR, Roberts JP, Ascher NL. Histopathologic study of transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol, Nov/1991;2(4):549-56.

35 of 60

Prepared: December 9, 201432. Sterneck M, Wiesner R, Ascher N, Roberts J, Ferrell L, Ludwig J, Lake J. Azathioprine hepatotoxicity after liver transplantation. Hepatology, Nov/1991;14(5):806-10.

33. Prager MC, Johnson KL, Ascher NL, Roberts JP. Anesthetic care of patients with Crigler-Najjar syndrome. Anesth Analg, Jan/1992;74(1):162-4.

34. Krams SM, Falco DA, Villanueva JC, Rabkin J, Tomlanovich SJ, Vincenti F, Amend WJ, Melzer J, Garovoy MR, Roberts JP. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation, Jan/1992;53(1):151-6.

35. Martinez OM, Krams SM, Sterneck M, Villanueva JC, Falco DA, Ferrell LD, Lake J, Roberts JP, Ascher NL. Intragraft cytokine profile during human liver allograft rejection. Transplantation, Feb/1992;53(2):449-56.

36. Lake JR, Roberts JP, Ascher NL. Maintenance immunosuppression after liver transplantation. Semin Liver Dis, Feb/1992;12(1):73-9.

37. Ring EJ, Lake JR, Roberts JP, Gordon RL, LaBerge JM, Read AE, Sterneck MR, Ascher NL. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med, Feb/15/1992;116(4):304-9.

38. Wright TL, Mamish D, Combs C, Kim M, Donegan E, Ferrell L, Lake J, Roberts J, Ascher NL. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet, Apr/18/1992;339(8799):952-5.

39. Liu T, Freise CE, Ferrell L, Ascher NL, Roberts JP. A modified vascular "sleeve" anastomosis for rearterialization in orthotopic liver transplantation in rats. Transplantation, Jul/1992;54(1):179-80.

40. Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, Wright TL, Ascher NL, Roberts JP, Scharschmidt BF, Lake JR. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology, Jul/1992;16(1):1-7.

41. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, Fennessy S, Roberts JP, Ascher NL. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology, Jul/1992;103(1):317-22.

42. Prager MC, Cauldwell CA, Ascher NL, Roberts JP, Wolfe CL. Pulmonary hypertension associated with liver disease is not reversible after liver transplantation. Anesthesiology, Aug/1992;77(2):375-8.

43. LaBerge JM, Ring EJ, Lake JR, Ferrell LD, Doherty MM, Gordon RL, Roberts JP, Peltzer MY, Ascher NL. Transjugular intrahepatic portosystemic shunts: preliminary results in 25 patients. J Vasc Surg, Aug/1992;16(2):258-67.

44. Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J. Hepatitis C viral infection in liver transplant recipients. Hepatology, Oct/1992;16(4):865-76.

45. Sollinger HW, Belzer FO, Deierhoi MH, Diethelm AG, Gonwa TA, Kauffman RS, Klintmalm GB, McDiarmid SV, Roberts J, Rosenthal JT. RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection. Ann Surg, Oct/1992;216(4):513-8; discussion 518-9.

46. Hebert MF, Roberts JP, Prueksaritanont T, Benet LZ. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin Pharmacol Ther, Nov/1992;52(5):453-7.

36 of 60

Prepared: December 9, 201447. Ferrell L, Wright T, Lake J, Roberts J, Ascher N. Incidence and diagnostic features of macroregenerative nodules vs. small hepatocellular carcinoma in cirrhotic livers. Hepatology, Dec/1992;16(6):1372-81.

48. Ferrell L, Bass N, Roberts J, Ascher N. Lipopeliosis: fat induced sinusoidal dilatation in transplanted liver mimicking peliosis hepatis. J Clin Pathol, Dec/1992;45(12):1109-10.

49. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation at the University of California, San Francisco. Clin Transpl, 1993;175-7.

50. Muhler, A, Freise, C, Kuwatsuru, R, Liu, T, Roberts, JR, and Brasch, RC. Acute liver rejection: evaluation with cell-directed MR contrast agents in a rat transplant model. Radiology, 1993;186:139.

51. Martinez OM, Ascher NL, Ferrell L, Villanueva J, Lake J, Roberts JP, Krams SM. Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation, Apr/1993;55(4):909-18.

52. Greeve M, Ferrell L, Kim M, Combs C, Roberts J, Ascher N, Wright TL. Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes. Hepatology, Apr/1993;17(4):593-8.

53. Martinez OM, Villanueva JC, Lake J, Roberts JP, Ascher NL, Krams SM. IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro. Transplantation, May/1993;55(5):1159-66.

54. Osorio RW, Freise CE, Stock PG, Lake JR, Laberge JM, Gordon RL, Ring EJ, Ascher NL, Roberts JP. Nonoperative management of biliary leaks after orthotopic liver transplantation. Transplantation, May/1993;55(5):1074-7.

55. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, Ascher NL. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology, May/1993;187(2):413-20.

56. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation for fulminant hepatic failure. Arch Surg, Jun/1993;128(6):677-82.

57. Bumgardner GL, Roberts JP. New immunosuppressive agents. Gastroenterol Clin North Am, Jun/1993;22(2):421-49.

58. Osorio RW, Ascher NL, Jaenisch R, Freise CE, Roberts JP, Stock PG. Major histocompatibility complex class I deficiency prolongs islet allograft survival. Diabetes, Oct/1993;42(10):1520-7.

59. Hebert MF, Roberts JP. Endstage liver disease associated with nitrofurantoin requiring liver transplantation. Ann Pharmacother, Oct/1993;27(10):1193-4.

60. Roberts JP, Lake JR, Hebert M, Nikolai B, Ascher NL, Ferrell LD. Reversal of chronic rejection after treatment failure with FK506 and RS61443. Transplantation, Oct/1993;56(4):1021-3.

61. Chazouillères O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, Ascher NL, Wright TL. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet, Jan/15/1994;343(8890):142-6.

62. Freise CE, Liu T, Hong K, Osorio RW, Papahadjopoulos D, Ferrell L, Ascher NL, Roberts JP. The increased efficacy and decreased nephrotoxicity of a cyclosporine liposome. Transplantation, Mar/27/1994;57(6):928-32.

37 of 60

Prepared: December 9, 201463. Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, Ascher NL, Neuwald P, Wilber J, Urdea M. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology, Apr/1994;106(4):994-9.

64. Kuwatsuru R, Liu T, Cohen F, Shames DM, Osorio RW, Mann J, Rosenau W, Mühler A, Neuder MS, Roberts JP. Acute liver transplantation rejection. Early detection of endothelial leak in a rat model using magnetic resonance imaging and a macromolecular contrast medium. Invest Radiol, Jun/1994;29 Suppl 2:S297-9.

65. Osorio RW, Ascher NL, Avery M, Bacchetti P, Roberts JP, Lake JR. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology, Jul/1994;20(1 Pt 1):105-10.

66. Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology, Jul/1994;20(1 Pt 2):24S-27S.

67. Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, Roberts J, Wilber J, Sheridan P, Urdea M. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology, Oct/1994;20(4 Pt 1):773-9.

68. Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation, Jan/27/1995;59(2):230-4.

69. Somberg KA, Riegler JL, LaBerge JM, Doherty-Simor MM, Bachetti P, Roberts JP, Lake JR. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol, Apr/1995;90(4):549-55.

70. LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK, Ascher NL, Roberts JP, Simor MM, Doherty CA, Hahn J. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology, Apr/1995;108(4):1143-51.

71. Wacher VJ, Liu T, Roberts JP, Ascher NL, Benet LZ. Time course of cyclosporine and ist motabolites in blood, liver and spleen of naive Lewis rats: comparison with preliminary data obtained in transplanted animals. Biopharm Drug Dispos, May/1995;16(4):303-12.

72. Venook AP, Ferrell LD, Roberts JP, Emond J, Frye JW, Ring E, Ascher NL, Lake JR. Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg, Jul/1995;1(4):242-8.

73. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology, Aug/1995;22(2):451-7.

74. Emond J, Wachs ME, Renz JF, Kelley S, Harris H, Roberts JP, Ascher NL, Lim RC. Total vascular exclusion for major hepatectomy in patients with abnormal liver parenchyma. Arch Surg, Aug/1995;130(8):824-30; discussion 830-1.

75. Wilson MW, Gordon RL, LaBerge JM, Kerlan RK, Radosevich PM, Roberts JP, Ring EJ. Liver transplantation complicated by malpositioned transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol, 9/1995;6(5):695-9.

76. Freise CE, Liu T, Osorio RW, Ferrell L, Ascher NL, Roberts JP. Increased efficacy of CSA following rearterialization in the rat OLTX model. J Surg Res, Oct/1995;59(4):493-6.

38 of 60

Prepared: December 9, 201477. Renz JF, Mudge CL, Heyman MB, Tomlanovich S, Kingsford RP, Moore BJ, Snyder JD, Perr HA, Paschal AL, Roberts JP. Donor selection limits use of living-related liver transplantation. Hepatology, Oct/1995;22(4 Pt 1):1122-6.

78. Ferrell LD, Lee R, Brixko C, Bass NM, Lake JR, Roberts JP, Ascher N, Rabkin J. Hepatic granulomas following liver transplantation. Clinicopathologic features in 42 patients. Transplantation, Nov/15/1995;60(9):926-33.

79. Donegan E, Wright TL, Roberts J, Ascher NL, Lake JR, Neuwald P, Wilber J, Quan S, Kuramoto IK, Dinello RK. Detection of hepatitis C after liver transplantation. Four serologic tests compared. Am J Clin Pathol, Dec/1995;104(6):673-9.

80. Freise CE, Stock PG, Roberts JP, Melzer JS. Low postoperative wound infection rates are possible following simultaneous pancreas-kidney transplantation. Transplant Proc, Dec/1995;27(6):3069-70.

81. Ferrell LD, Roberts JP. Liver. Pathology (Phila), 1996;3(2):367-78.

82. Gournay J, Ferrell LD, Roberts JP, Ascher NL, Wright TL, Lake JR. Cryoglobulinemia presenting after liver transplantation. Gastroenterology, Jan/1996;110(1):265-70.

83. Randall, HB, and Roberts, JP. Surgical reconstruction of biliary tract following orthotopic liver transplantation. Current Opinion in Organ Transplantation, 1996;1:82-88.

84. Randall HB, Wachs ME, Somberg KA, Lake JR, Emond JC, Ascher NL, Roberts JP. The use of the T tube after orthotopic liver transplantation. Transplantation, Jan/27/1996;61(2):258-61.

85. Brown RS, Lake JR, Katzman BA, Ascher NL, Somberg KA, Emond JC, Roberts JP. Incidence and significance of Aspergillus cultures following liver and kidney transplantation. Transplantation, Feb/27/1996;61(4):666-9.

86. Terrault NA, Holland CC, Ferrell L, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transpl Surg, Mar/1996;2(2):132-8.

87. Croutch KL, Gordon RL, Ring EJ, Kerlan RK, LaBerge JM, Roberts JP. Superselective arterial embolization in the liver transplant recipient: a safe treatment for hemobilia caused by percutaneous transhepatic biliary drainage. Liver Transpl Surg, Mar/1996;2(2):118-23.

88. Emond JC, Kelley SD, Heffron TG, Nakagawa T, Roberts JP, Lim RC. Surgical and anesthetic management of patients undergoing major hepatectomy using total vascular exclusion. Liver Transpl Surg, Mar/1996;2(2):91-8.

89. Freise CE, Liu T, Ascher NL, Roberts JP. Hepatotoxins and liver transplantation decrease pulmonary metastases in rats with hepatoma. J Surg Res, Aug/1996;64(2):198-202.

90. Kuang AA, Rosenthal P, Roberts JP, Renz JF, Stock P, Ascher NL, Emond JC. Decreased mortality from technical failure improves results in pediatric liver transplantation. Arch Surg, Aug/1996;131(8):887-92; discussion 892-3.

91. Roberts JP, Liu T, Freise CE, Mielczarek J, Ferrell L, Randall H, Ascher NL. Liver transplantation improves survival of rats bearing hepatoma-3924A. J Surg Res, Sep/1996;65(1):59-62.

92. Kuang AA, Renz JF, Ferrell LD, Ring EJ, Rosenthal P, Lim RC, Roberts JP, Ascher NL, Emond JC. Failure patterns of cryopreserved vein grafts in liver transplantation. Transplantation, Sep/27/1996;62(6):742-7.

39 of 60

Prepared: December 9, 201493. Emond JC, Renz JF, Ferrell LD, Rosenthal P, Lim RC, Roberts JP, Lake JR, Ascher NL. Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg, Oct/1996;224(4):544-52; discussion 552-4.

94. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P, Roberts JP, Lake JR, Ascher NL, Wright TL. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology, Nov/1996;24(5):1041-6.

95. Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology, Dec/1996;24(6):1327-33.

96. Berenguer M, Terrault NA, Piatak M, Yun A, Kim JP, Lau JY, Lake JR, Roberts JR, Ascher NL, Ferrell L, Wright TL. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology, Dec/1996;111(6):1569-75.

97. Reiser M, Terrault N, Nelson DR, Mizokami M, Ferrell L, Lake JR, Roberts JP, Ascher NL, Wright TL, Lau JY. Antibody to the host cellular gene-derived epitope GOR-1 in liver transplant recipients with hepatitis C virus infection. Transplantation, Feb/27/1997;63(4):609-12.

98. Pessoa MG, Terrault NA, Ferrell LD, Kim JP, Kolberg J, Detmer J, Collins ML, Yun AJ, Viele M, Lake JR, Roberts JP, Ascher NL, Wright TL. Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation. Hepatology, May/1997;25(5):1266-70.

99. Floren LC, Bekersky I, Benet LZ, Mekki Q, Dressler D, Lee JW, Roberts JP, Hebert MF. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin Pharmacol Ther, Jul/1997;62(1):41-9.

100. Sher LS, Cosenza CA, Michel J, Makowka L, Miller CM, Schwartz ME, Busuttil R, McDiarmid S, Burdick JF, Klein AS, Esquivel C, Klintmalm G, Levy M, Roberts JP, Lake JR, Kalayoglu M, D'Alessandro AM, Gordon RD, Stieber AC, Shaw BW, Thistlethwaite JR, Whittington P, Wiesner RH, Porayko M, Cosimi AB. Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. Transplantation, Jul/27/1997;64(2):258-63.

101. Rosenthal P, Roberts JP, Ascher NL, Emond JC. Auxiliary liver transplant in fulminant failure. Pediatrics, Aug/1997;100(2):E10.

102. Roberts JP. T tube or no T tube? Liver Transpl Surg, Sep/1997;3(5 Suppl 1):S20-1.

103. Renz JF, Rosenthal P, Roberts JP, Ascher NL, Emond JC. Planned exploration of pediatric liver transplant recipients reduces posttransplant morbidity and lowers length of hospitalization. Arch Surg, Sep/1997;132(9):950-5; discussion 955-6.

104. Brown, RS Jr, Ascher, NL, Lake, JR, Emond, JC, Bacchetti, P, Randall, HB, and Roberts, JP. The impact of surgical complications following liver transplantation on resource utilization. Arch Surg, 10/1997;132(10):1098-1103.

105. Rosenthal P, Emond JC, Heyman MB, Snyder J, Roberts J, Ascher N, Ferrell L. Pathological changes in yearly protocol liver biopsy specimens from healthy pediatric liver recipients. Liver Transpl Surg, Nov/1997;3(6):559-62.

106. Roberts, JP. Opinions in favor of wider organ sharing Current Opinion Organ Transplant, 1998;3(3):159-162.

40 of 60

Prepared: December 9, 2014107. Brown RS, Lake JR, Ascher NL, Emond JC, Roberts JP. Predictors of the cost of liver transplantation. Liver Transpl Surg, Mar/1998;4(2):170-6.

108. Rouillard SS, Bass NM, Roberts JP, Doherty CA, Gee L, Bacchetti P, Somberg KA. Severe hyperbilirubinemia after creation of transjugular intrahepatic portosystemic shunts: natural history and predictors of outcome. Ann Intern Med, Mar/1/1998;128(5):374-7.

109. Brown RS, Brumage L, Yee HF, Lake JR, Roberts JP, Somberg KA. Enterococcal bacteremia after transjugular intrahepatic portosystemic shunts (TIPS). Am J Gastroenterol, Apr/1998;93(4):636-9.

110. Freise CE, Galbraith CA, Nikolai BJ, Ascher NL, Lake JR, Stock PG, Roberts JP. Risks associated with conversion of stable patients after liver transplantation to the microemulsion formulation of cyclosporine. Transplantation, Apr/15/1998;65(7):995-7.

111. Lattyak BV, Rosenthal P, Mudge C, Roberts JP, Renze JF, Osorio RW, Emond JC, Lalwani AK. Posttransplant lymphoproliferative disorder presenting in the head and neck. Laryngoscope, Aug/1998;108(8 Pt 1):1195-8.

112. Terrault NA, Zhou S, McCory RW, Pruett TL, Lake JR, Roberts JP, Ascher NL, Wright TL. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology, Aug/1998;28(2):555-61.

113. Reichert PR, Renz JF, Rosenthal P, Bacchetti P, Lim RC, Roberts JP, Ascher NL, Emond JC. Biliary complications of reduced-organ liver transplantation. Liver Transpl Surg, Sep/1998;4(5):343-9.

114. Pessoa MG, Terrault NA, Ferrell LD, Detmer J, Kolberg J, Collins ML, Viele M, Lake JR, Roberts JP, Ascher NL, Wright TL. Hepatitis after liver transplantation: the role of the known and unknown viruses. Liver Transpl Surg, Nov/1998;4(6):461-8.

115. Kita Y, Lake JR, Ferrell LD, Mori M, Roberts JP, Kakizoe S, Kiyosawa K, Tanaka E, Shiga J, Takikawa H, Inoue Y, Ohtake T, Ohtomo K, Yotsuyanagi H, Oka T, Harihara Y, Takayama T, Kubota K, Kawarasaki H, Hashikura Y, Kawasaki S, Ascher NL, Makuuchi M. Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: report of a case. Transplant Proc, Nov/1998;30(7):3321-3.

116. Narumi S, Osorio RW, Freise CE, Stock PG, Roberts JP, Ascher NL. Hepatic artery pseudoaneurysm with hemobilia following angioplasty after liver transplantation. Clin Transplant, Dec/1998;12(6):508-10.

117. Freise CE, Ferrell L, Liu T, Ascher NL, Roberts JP. Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma. Transplantation, Feb/27/1999;67(4):510-3.

118. Renz JF, Lightdale J, Mudge C, Bacchetti P, Watson J, Ascher NL, Emond JC, Rosenthal P, Roberts JP. Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipients. Liver Transpl Surg, Mar/1999;5(2):136-43.

119. Hebert MF, Ascher NL, Lake JR, Emond J, Nikolai B, Linna TJ, Roberts JP. Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients. Transplantation, Mar/15/1999;67(5):707-12.

120. Narumi S, Hakamada K, Sasaki M, Freise CE, Stock PG, Roberts JP, Ascher NL. Liver transplantation for autoimmune hepatitis: rejection and recurrence. Transplant Proc, Aug/1999;31(5):1955-6.

41 of 60

Prepared: December 9, 2014121. Yao FY, Osorio RW, Roberts JP, Poordad FF, Briceno MN, Garcia-Kennedy R, Gish RR. Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation. Liver Transpl Surg, Nov/1999;5(6):491-6.

122. Edwards EB, Roberts JP, McBride MA, Schulak JA, Hunsicker LG. The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med, Dec/30/1999;341(27):2049-53.

123. Hirose R, Roberts JP, Quan D, Osorio RW, Freise C, Ascher NL, Stock PG. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. Transplantation, Jan/27/2000;69(2):307-11.

124. O'Rourke RW, Osorio RW, Freise CE, Lou CD, Garovoy MR, Bacchetti P, Ascher NL, Melzer JS, Roberts JP, Stock PG. Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants. Clin Transplant, Apr/2000;14(2):167-73.

125. Lee CM, Carter JT, Alfrey EJ, Ascher NL, Roberts JP, Freise CE. Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation. Arch Surg, Sep/2000;135(9):1016-9; discussion 1019-20.

126. Renz JF, Roberts JP. Long-term complications of living donor liver transplantation. Liver Transpl, Nov/2000;6(6 Suppl 2):S73-6.

127. Chang GJ, Mahanty HD, Quan D, Freise CE, Ascher NL, Roberts JP, Stock PG, Hirose R. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated. Liver Transpl, Nov/2000;6(6):734-40.

128. Reichert PR, Renz JF, D'Albuquerque LA, Rosenthal P, Lim RC, Roberts JP, Ascher NL, Emond JC. Surgical anatomy of the left lateral segment as applied to living-donor and split-liver transplantation: a clinicopathologic study. Ann Surg, Nov/2000;232(5):658-64.

129. Chang GJ, Mahanty HD, Vincenti F, Freise CE, Roberts JP, Ascher NL, Stock PG, Hirose R. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function. Clin Transplant, Dec/2000;14(6):550-4.

130. Roberts, JP. What's new -- what's hot in clinical liver transplantation. Am J Transplant, 2001;18(35):19.

131. Koh BY, Rosenthal P, Medeiros LJ, Osorio RW, Roberts JP, Ascher NL, Gelb AB. Posttransplantation lymphoproliferative disorders in pediatric patients undergoing liver transplantation. Arch Pathol Lab Med, Mar/2001;125(3):337-43.

132. Roberts J. Clinical liver transplantation. Am J Transplant, May/2001;1(1):18-20.

133. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology, Jun/2001;33(6):1394-403.

134. Mahanty HD, Cherikh WS, Chang GJ, Baxter-Lowe LA, Roberts JP. Influence of pretransplant pregnancy on survival of renal allografts from living donors. Transplantation, Jul/27/2001;72(2):228-32.

135. Kashef E, Roberts JP. Transplantation for hepatocellular carcinoma. Semin Oncol, Oct/2001;28(5):497-502.

42 of 60

Prepared: December 9, 2014136. Renz JF, de Roos M, Rosenthal P, Mudge C, Bacchetti P, Watson J, Roberts JP, Ascher NL, Emond JC. Posttransplantation growth in pediatric liver recipients. Liver Transpl, Dec/2001;7(12):1040-55.

137. Roberts JP. Prioritization of patients with liver cancer within the MELD system. Liver Transpl, Apr/2002;8(4):329-30.

138. Diaz GC, Renz JF, Mudge C, Roberts JP, Ascher NL, Emond JC, Rosenthal P. Donor health assessment after living-donor liver transplantation. Ann Surg, Jul/2002;236(1):120-6.

139. Toyoki Y, Renz JF, Mudge C, Ascher NL, Roberts JP, Rosenthal P. Allograft rejection in pediatric liver transplantation: Comparison between cadaveric and living related donors. Pediatr Transplant, Aug/2002;6(4):301-7.

140. Chang GJ, Liu T, Feng S, Bedolli M, O'rourke RW, Schmidt G, Roberts JP, Stock PG. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts. Surgery, Aug/2002;132(2):149-56.

141. Rosengard BR, Feng S, Alfrey EJ, Zaroff JG, Emond JC, Henry ML, Garrity ER, Roberts JP, Wynn JJ, Metzger RA, Freeman RB, Port FK, Merion RM, Love RB, Busuttil RW, Delmonico FL. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant, Sep/2002;2(8):701-11.

142. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl, Sep/2002;8(9):765-74.

143. Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl, Oct/2002;8(10):873-83.

144. Niemann CU, Roberts JP, Ascher NL, Yost CS. Intraoperative hemodynamics and liver function in adult-to-adult living liver donors. Liver Transpl, Dec/2002;8(12):1126-32.

145. Roberts JP, Brown RS, Edwards EB, Farmer DG, Freeman RB, Wiesner RH, Merion RM. Liver and intestine transplantation. Am J Transplant, 2003;3 Suppl 4:78-90.

146. Hebert MF, Wacher VJ, Roberts JP, Benet LZ. Pharmacokinetics of cyclosporine pre- and post-liver transplantation. J Clin Pharmacol, Jan/2003;43(1):38-42.

147. Finley DS, Roberts JP. Frequent salvage of ruptured renal allografts: a large single center experience. Clin Transplant, Apr/2003;17(2):126-9.

148. McTaggart RA, Gottlieb D, Brooks J, Bacchetti P, Roberts JP, Tomlanovich S, Feng S. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant, Apr/2003;3(4):416-23.

149. Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, Ascher NL, Roberts JP. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl, Jul/2003;9(7):684-92.

150. Posselt AM, Vincenti F, Bedolli M, Lantz M, Roberts JP, Hirose R. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients. Transplantation, Jul/15/2003;76(1):190-5.

43 of 60

Prepared: December 9, 2014151. Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation, Jul/27/2003;76(2):370-5.

152. Roberts JP. Role of adult living liver donation in patients with hepatocellular cancer. Liver Transpl, Oct/2003;9(10 Suppl 2):S60-3.

153. Roberts JP, Nikolai B, Tomlanovich S. Cost of organ procurement and transplantation network data collection for a large transplant center. Am J Transplant, Oct/2003;3(10):1316-7.

154. Chang GJ, Mahanty HD, Ascher NL, Roberts JP. Expanding the donor pool: can the Spanish model work in the United States? Am J Transplant, Oct/2003;3(10):1259-63.

155. Freeman RB, Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM. Improving liver allocation: MELD and PELD. Am J Transplant, 2004;4 Suppl 9:114-31.

156. Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology, Jan/2004;39(1):230-8.

157. Roberts JP, Wolfe RA, Bragg-Gresham JL, Rush SH, Wynn JJ, Distant DA, Ashby VB, Held PJ, Port FK. Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. N Engl J Med, Feb/5/2004;350(6):545-51.

158. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl, Mar/2004;10(3):349-55.

159. Yeh BM, Breiman RS, Taouli B, Qayyum A, Roberts JP, Coakley FV. Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience. Radiology, Mar/2004;230(3):645-51.

160. Roberts JP, Hulbert-Shearon TE, Merion RM, Wolfe RA, Port FK. Influence of graft type on outcomes after pediatric liver transplantation. Am J Transplant, Mar/2004;4(3):373-7.

161. Yao FY, Bass NM, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver Transpl, May/2004;10(5):621-30.

162. Niemann CU, Hirose R, Stock P, Roberts JP, Mandell S, Spencer Yost C. Intraoperative fluid management of living donor versus cadaveric liver transplant recipients. Transplant Proc, Jun/2004;36(5):1466-8.

163. Roberts JP. An eye to quality. Am J Transplant, Jun/2004;4(6):844-5.

164. Yao FY, Roberts JP. Applying expanded criteria to liver transplantation for hepatocellular carcinoma: too much too soon, or is now the time? Liver Transpl, Jul/2004;10(7):919-21.

165. Miller GA, Yeh BM, Breiman RS, Roberts JP, Qayyum A, Coakley FV. Use of CT cholangiography to evaluate the biliary tract after liver transplantation: initial experience. Liver Transpl, Aug/2004;10(8):1065-70.

166. McTaggart RA, Tomlanovich S, Bostrom A, Roberts JP, Feng S. Comparison of outcomes after delayed graft function: sirolimus-based versus other calcineurin-inhibitor sparing induction immunosuppression regimens. Transplantation, Aug/15/2004;78(3):475-80.

44 of 60

Prepared: December 9, 2014167. Olthoff KM, Brown RS, Delmonico FL, Freeman RB, McDiarmid SV, Merion RM, Millis JM, Roberts JP, Shaked A, Wiesner RH, Lucey MR. Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl, Oct/2004;10(10 Suppl 2):A6-22.

168. Visser BC, Suh I, Hirose S, Rosenthal P, Lee H, Roberts JP, Hirose R. The influence of portoenterostomy on transplantation for biliary atresia. Liver Transpl, Oct/2004;10(10):1279-86.

169. Vulchev A, Roberts JP, Stock PG. Ethical issues in split versus whole liver transplantation. Am J Transplant, Nov/2004;4(11):1737-40.

170. Posselt AM, Mahanty H, Kang SM, Stoller ML, Meng MV, Roberts JP, Freise CE. Laparoscopic right donor nephrectomy: a large single-center experience. Transplantation, Dec/15/2004;78(11):1665-9.

171. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology, Jan/2005;41(1):32-9.

172. Shergill AK, Khalili M, Straley S, Bollinger K, Roberts JP, Ascher NA, Terrault NA. Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am J Transplant, Jan/2005;5(1):118-24.

173. Chen JS, Yeh BM, Wang ZJ, Roberts JP, Breiman RS, Qayyum A, Coakley FV. Concordance of second-order portal venous and biliary tract anatomies on MDCT angiography and MDCT cholangiography. AJR Am J Roentgenol, Jan/2005;184(1):70-4.

174. Thornton RH, Kerlan RK, Gordon RL, Laberge JM, Wilson MW, Wolanske KA, Roberts JP. Percutaneous salvage of a failing rex shunt. J Vasc Interv Radiol, Mar/2005;16(3):399-402.

175. Choi S, Noh J, Hirose R, Ferell L, Bedolli M, Roberts JP, Niemann CU. Mild hypothermia provides significant protection against ischemia/reperfusion injury in livers of obese and lean rats. Ann Surg, Mar/2005;241(3):470-6.

176. Feng S, Roberts J. An older liver in the hand, or a (possibly) younger liver in the bush? Am J Transplant, Mar/2005;5(3):425-7.

177. Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R, Kerlan R, Venook A, Ascher NL, Emond JC, Roberts JP. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant, Apr/2005;5(4 Pt 1):795-804.

178. Kusano T, Randall HB, Roberts JP, Ascher NL. The use of stents for duct-to-duct anastomoses of biliary reconstruction in orthotopic liver transplantation. Hepatogastroenterology, 5/2005;52(63):695-9.

179. Serkova NJ, Jackman M, Brown JL, Liu T, Hirose R, Roberts JP, Maher JJ, Niemann CU. Metabolic profiling of livers and blood from obesse Zucker rats J Hepatol, 5/2005;44(5):956-62.

180. Carter JT, Freise CE, McTaggart RA, Mahanty HD, Kang SM, Chan SH, Feng S, Roberts JP, Posselt AM. Laparoscopic procurement of kidneys with multiple renal arteries is associated with increased ureteral complications in the recipient. Am J Transplant, Jun/2005;5(6):1312-8.

181. Wang ZJ, Yeh BM, Roberts JP, Breiman RS, Qayyum A, Coakley FV. Living donor candidates for right hepatic lobe transplantation: evaluation at CT cholangiography--initial experience. Radiology, Jun/2005;235(3):899-904.

182. Cruz E, Ascher NL, Roberts JP, Bass NM, Yao FY. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome. Clin Transplant, Aug/2005;19(4):501-6.

45 of 60

Prepared: December 9, 2014183. Serkova NJ, Jackman M, Brown JL, Liu T, Hirose R, Roberts JP, Maher JJ, Niemann CU. Metabolic profiling of livers and blood from obese Zucker rats. J Hepatol, Aug/2/2005.

184. Roberts JP. Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation. Liver Transpl, Nov/2005;11(11 Suppl 2):S45-6.

185. Carter JT, Chan S, Roberts JP, Feng S. Expanded criteria donor kidney allocation: marked decrease in cold ischemia and delayed graft function at a single center. Am J Transplant, Nov/2005;5(11):2745-53.

186. Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl, Dec/2005;11(12):1505-14.

187. Niemann CU, Hirose R, Liu T, Behrends M, Brown JL, Kominsky DF, Roberts JP, Serkova N. Ischemic preconditioning improves energy state and transplantation survival in obese Zucker rat livers. Anesth Analg, Dec/2005;101(6):1577-83.

188. Khalili M, Vardanian AJ, Hamerski CM, Wang R, Bacchetti P, Roberts JP, Terrault NA. Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years. Clin Transplant, Jan/2006;20(1):1-9.

189. Niemann CU, Behrends M, Quan D, Eilers H, Gropper MA, Roberts JP, Hirose R. Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores. Transfus Med, Apr/2006;16(2):93-100.

190. Feng S, Si M, Taranto SE, McBride MA, Mudge C, Stritzel S, Roberts JP, Rosenthal P. Trends over a decade of pediatric liver transplantation in the United States. Liver Transpl, Apr/2006;12(4):578-84.

191. Hirsch J, Hansen KC, Choi S, Noh J, Hirose R, Roberts JP, Matthay MA, Burlingame AL, Maher JJ, Niemann CU. Warm ischemia induced alterations in oxidative and inflammatory proteins in hepatic Kupffer cells in rats. Mol Cell Proteomics, June/2006;5((6)):979-986.

192. Feng S, Barr M, Roberts J, Oberbauer R, Kaplan B. Developments in clinical islet, liver thoracic, kidney and pancreas transplantation in the last 5 years. Am J Transplant, Aug/2006;6(8):1759-67.

193. Roberts JP, Dykstra DM, Goodrich NP, Rush SH, Merion RM, Port FK. Geographic Differences in Event Rates by Model for End-Stage Liver Disease Score. Am J Transplant, Aug/29/2006.

194. Yao FY, Gautam M, Palese C, Rebres R, Terrault N, Roberts JP, Peters MG. De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant, 9/2006;20(5):617:23.

195. Niemann CU, Choi S, Behrends M, Hirose R, Noh J, Coatney JL, Roberts JP, Serkova NJ, Maher JJ. Mild hypothermia protects obese rats from fulminant hepatic necrosis induced by ischemia-reperfusion. Surgery, 9/2006;140(3):404-12.

196. Roberts JP, Dykstra DM, Goodrich NP, Rush SH, Merion RM, Port FK. Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant, 10/2006;6(10):2470-5.

197. Roberts JP, Neill A, Goldstein R. The use of a micro-bubble contrast agent to allow visualization of the biliary tree. Clin Transplant, 11/2006;20((6)):740-2..

198. O'Brien MJ, Bloom A, LaBerge JM, Roberts JP, Rosenthal P, Kerlan RK,. SIR Foundation 2006 Annual Meeting Film Panel Case: Budd-Chiari syndrome in a patient with Cogan syndrome. J Vasc Interv Radiol, Dec/2006;17(12):1881-3.

46 of 60

Prepared: December 9, 2014199. Yeh BM, Coakley FV, Westphalen AC, Joe BN, Freise CE, Qayyum A, McTaggart RA, Roberts JP. Predicting biliary complications in right lobe liver transplant recipients according to distance between donor's bile duct and corresponding hepatic artery. Radiology, Jan/2007;242(1):144-51.

200. Park Y, Hirose R, Coatney JL, Ferrell L, Behrends M, Roberts JP, Serkova NJ, Niemann CU. Ischemia-reperfusion injury is more severe in older versus young rat livers. J Surg Res, Jan/2007;137(1):96-102.

201. Niemann CU, Feiner J, Behrends M, Eilers H, Ascher NL, Roberts JP. Central venous pressure monitoring during living right donor hepatectomy. Liver Transpl, Feb/2007;13(2):266-71.

202. Chao SD, Roberts JP, Farr M, Yao FY. Short waitlist time does not adversely impact outcome following liver transplantation for hepatocellular carcinoma. Am J Transplant, Jun/2007;7(6):1594-600.

203. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant, Nov/2007;7(11):2587-96.

204. Ponrartana S, Coakley FV, Yeh BM, Breiman RS, Qayyum A, Joe BN, Poder L, Lu Y, Gibbs VC, Roberts JP. Accuracy of plain abdominal radiographs in the detection of retained surgical needles in the peritoneal cavity. Ann Surg, Jan/2008;247(1):8-12.

205. Park Y, Hirose R, Dang K, Xu F, Behrends M, Tan V, Roberts JP, Niemann CU. Increased severity of renal ischemia-reperfusion injury with venous clamping compared to arterial clamping in a rat model. Surgery, Feb/2008;143(2):243-51.

206. Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, Freise CE, Benet LZ, Ascher NL, Roberts JP, Murphy B, Keller MJ, Olthoff KM, Blumberg EA, Brayman KL, Bartlett ST, Davis CE, McCune JM, Bredt BM, Stablein DM, Stock PG. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant, Feb/2008;8(2):355-65.

207. Pomfret EA, Sung RS, Allan J, Kinkhabwala M, Melancon JK, Roberts JP. Solving the organ shortage crisis: the 7th annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium. Am J Transplant, Apr/2008;8(4):745-52.

208. Breiman RS, Coakley FV, Webb EM, Ellingson JJ, Roberts JP, Kohr J, Lutz J, Knoess N, Yeh BM. CT cholangiography in potential liver donors: effect of premedication with intravenous morphine on biliary caliber and visualization. Radiology, Jun/2008;247(3):733-37.

209. Hirsch J, Niemann CU, Choi J, Theodore P, Hirose R, Roberts JP, Burlingame AL, Matthay M. Alterations in the proteome of pulmonary alveolar type II cells in the rat after liver ischemia. Crit Care Med, Jun/2008;36(6):1846-54.

210. Balan V, Ruppert K, Demetris AJ, Ledneva T, Duquesnoy RJ, Detre KM, Wei YL, Rakela J, Schafer DF, Roberts JP, Everhart JE, Wiesner RH. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Hepatology, Sept/2008;48(3):878-88.

211. Yao FY, Kerlan RK Jr, Hirose R, Dvern TJ 3rd, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP. Excellent outcomes following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology, Sep/2008;48(3):819-27.

212. Kuo A, Tan V, Lan B, Khalili M, Feng S, Roberts JP, Terrault NA. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection. Liver Transpl, Oct/2008;14(10):1491-7.

47 of 60

Prepared: December 9, 2014213. Abecassis MM, Burke R, Cosimi AB, Matas AJ, Merion RM, Millman D, Roberts JP, Klintmalm GB; American Society of Transplant Surgeons. Transplant center regulations--a mixed blessing? An ASTS Council viewpoint. Am J Transplant, Dec/2008;8(12):2496-502.

214. Blasi-Ibanez A, Hirose R, Feiner J, Freise C, Stock PG, Roberts JP, Niemann CU. Predictors associated with terminal renal function in deceased organ donors in the intensive care unit. Anesthesiology, Feb/2009;110(2):333-41.

215. Sharma M, Yong C, Majure D, Zellner C, Roberts JP, Bass NM, Ports TA, Yeghiazarians Y, Gregoratos G, Boyle AJ. Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation. Am J Cardiol, Mar/2009;103(5):742-6.

216. Abecassis MM, Burke R, Klintmalm GB, Matas AJ, Merion RM, Millman D, Olthoff K, Roberts JP; American Society of Transplant Surgeons. American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant, Jun/2009;9(6):1279-86.

217. Freeman RB, Matas AT, Henry M, Segev DL, Kaufman DB, Roberts JP. Moving kidney allocation forward: the ASTS perspective. Am J Transplant, Jul/2009;9(7):1501-6.

218. Tavakol MM, Vincenti FG, Assadi H, Frederick MJ, Tomlanovich SJ, Roberts JP, Posselt AM. Long-term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephrol, Jul/2009;4(7):1230-8.

219. Reich DJ, Mulligan DC, Abt PL, Pruett TL, Abecassis MM, D'Alessandro A, Pomfret EA, Freeman RB, Markmann JF, Hanto DW, Matas AJ, Roberts JP, Merion RM, Klintmalm GB; ASTS Standards on Organ Transplantation Committee. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant, Sep/2009;9(9):2004-11.

220. Rodrigue JR, Crist K, Roberts JP, Freeman RB Jr, Merion RM, Reed AI. Stimulus for organ donation: a survey of the American Society of Transplant Surgeons membership. Am J Transplant, Sep/2009;9(9):2172-6.

221. Biggins SW, Bambha K, Terrault N, Inadomi J, Roberts JP, Bass N. Transplant tourism to China: the impact on domestic patient-care decisions. Clin Transplant, Nov/2009;23(6):831-8.

222. Washburn WK, Meo NA, Halff GA, Roberts JP, Feng S. Factors influencing liver transplant length of stay at two large-volume transplant centers. Liver Transpl, Nov/2009;15(11):1570-8.

223. Reed AI, Merion RM, Roberts JP, Klintmalm GB, Abecassis MM, Olthoff KM, Langnas AN. The Declaration of Istanbul: review and commentary by the American Society of Transplant Surgeons Ethics Committee and Executive Committee. Am J Transplant, Nov/2009;9(11):2466-9 (Review).

224. Niemann CU, Walia A, Waldman J, Davio M, Roberts JP, Hirose R, Feiner J. Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin. Liver Transpl, Dec/2009;15(12):1852-60.

225. Botha JF, Langnas AN, Campos BD, Grant WJ, Freise CE, Ascher NL, Mercer DF, Roberts JP. Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl, May/2010;16(5):649-57.

226. Roberts JP, Venook A, Kerlan R, Yao F. Hepatocellular carcinoma: ablate and wait versus rapid transplantation. Liver Transpl, Aug/2010;16(8):925-29.

48 of 60

Prepared: December 9, 2014227. Melcher ML, Pomposelli JJ, Verbesey JE, McTaggart RA, Freise CE, Ascher NL, Roberts JP, Pomfret EA. Comparison of biliary complications in adult living-donor liver transplants performed at two busy transplant centers. Clin Transplant, Sep/Oct/2010;24(5):E137-44.

228. Ladabaum U, Cheng SL, Yao FY, Roberts JP. Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation. Clin Transplant, Mar/Apr/2011;25(2):283-91.

229. Melcher ML, Freise CE, Ascher NL, Roberts JP. Outcomes of surgical repair of bile leaks and strictures after adult-to-adult living donor liver transplant. Clin Transplant, Nov/2010;24:E230-35.

230. Burnett MM, Hess CP, Roberts JP, Bass NM, Douglas VC, Josephson SA. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg, Dec/2010;112:886-91.

231. Coffin CS, Mulrooney-Cousins PM, Peters MG, van Marle G, Roberts JP, Michalak TI, Terrault NA. Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. J Viral Hepat Jun/2011;18:415-23.

232. Segev DL, Veale JL, Berger JC, Hiller JM, Hanto RL, Leeser DB, Geffner SR, Shenoy S, Bry WI, Katznelson S, Melcher ML, Rees MA; Samara EN, Israni AK, Cooper M, Montgomery RJ, Malinzak L, Whiting J, Baran D, Tchervenkov JI, Roberts JP, Rogers J, Axelrod DA, Simpkins CE, Montgomery RA. Transporting live donor kidneys for kidney paired donation: initial national results. Am J Transplant, Feb/2011;11(2):356-60.

233. Reich DJ, Magee JC, Gifford K, Merion RM, Roberts JP, Klintmalm GB, Stock PG. Transplant surgery fellow perceptions about training and the ensuing job market -- are the right number of surgeons being trained? Am J Transplant, Feb/2011;11(2):253-60.

234. Lai JC, Feng S, Roberts JP, Terrault NA. Gender differences in liver donor quality are predictive of graft loss. Am J Transplant, Feb/2011;11(2):296-302.

235. Martinez AF, Bonacini M, Roberts JP. Image of the month. Portal hypertensive biliopathy. Arch Surg, May/2011;146(5):625-626.

236. Brandman D, Pingitore A, Lai JC, Roberts JP, Ferrell L, Bass NM, Terrault NA. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplan recipients with recurrent hepatitis C virus. Liver Transpl, Dec/2011;17(12):1380-6. doi: 10.1002/lt.22389.

237. Ahearn AJ, Posselt AM, Kang SM, Roberts JP, Freise CE. Experience with laparoscopic donor nephrectomy among more than 1000 cases: low complication rates, despite more challenging cases. Arch Surg Jul/2011;146(7):859-864.

238. Kwan SW, Fidelman N, Durack JC, Roberts JP, Kerlan RK Jr. Rex shunt preoperative imaging: diagnostic capability of imaging modalities. PLoS One, Jul/2011;6(7):e22222. [Epub 2011 Jul 12.]

239. Sapisochin G, Yao FY, Roberts JP. Do preoperative inflammatory markers impact on outcome after liver transplantation for hepatocellular carcinoma? Ann Surg, Aug/2011;254(2):383.

240. Ashby VB, Port FK, Wolfe RA, Wynn JJ, Williams WW, Roberts JP, Leichtman AB. Transplanting kidneys without points for HLA-B matching: consequences of the policy change. Am J Transplant, Aug/2011;11(8):1712-18.

241. Coffin CS, Mulrooney-Cousins PM, van Marle G, Roberts JP, Michalak TI, Terrault NA. Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy. Liver Transpl, Aug/2011;17(8):955-62.

49 of 60

Prepared: December 9, 2014242. Sapisochin G, Fidelman N, Roberts JP, Yao FY. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl, Aug/2011;17(8):934-42.

243. Mast DA, Vaughan W, Busque S, Veale JL, Roberts JP, Straube BM, Flores N, Canari C, Levy E, Tietjen A, Hil G, Melcher ML. Managing finances of shipping living donor kidneys for donor exchanges. Am J Transplant, Sep/2011;11(9):1810-14.

244. Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE. Outcomes with split liver transplantation in 106 recipients. The University of California, San Francisco, experience from 1993 to 2010. Arch Surg, Sep/2011;146(9):1052-1059.

245. Brandman D, Biggins SW, Hameed B, Roberts JP, Terrault NA. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality. Liver Int, Jan/2012;32(1):158-64. doi: 10.1111/j.1478-3231.2011.02618.x. Epub 2011 Sep 6.

246. Lai JC, Roberts JP, Vittinghoff E, Terrault NA, Feng S. Patient, center and geographic characteristics of nationally placed livers. Am J Transplant, Apr/2012;12(4):947-53. doi: 10.1111/j.1600-6143.2011.03961.x. Epub 2012 Feb 2.

247. Guy J, Kelley RK, Roberts J, Kerlan R, Yao F, Terrault N, Multidisciplinary management of hepatocellular carcinoma. Clin Gastroenterol and Hepatol, Apr/2012;10(4):354-62. Epub 2011 Nov 12.

248. Feng S, Ekong UD, Lobritto SJ, Demetris AJ, Roberts JP, Rosenthal P, Alonso EM, Philogene MC, Ikle D, Poole KM, Bridges ND, Turka LA, and Tchao NK. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA, 2012; 307(3): 283-93.

249. Perito ER, Lau A, Rhee S, Roberts JP, Rosenthal P. Posttransplant metabolic syndrome in children and adolescents after liver transplantation: a systematic review. Liver Transpl 2012 Sep;18(9):1009-28. doi: 10.1002/lt.23478

250. Perito ER, Glidden D, Roberts JP, Rosenthal P. Overweight and obesity in pediatric liver transplant recipients: prevalence and predictors before and after transplant, United Network for Organ Sharing Data, 1987-2010. Pediatr Transpl, Feb/2012;16(1):41-9. doi:10.1111/j.1399-3046.2011.01598.x.

251. Perito ER, Rhee S, Glidden D, Roberts JP, Rosenthal P. Impact of the donor body mass index on the survival of pediatric liver transplant recipients and post-transplant obesity. Liver Transpl. 2012 Aug; 18(8):930-9.

252. Vagefi PA, Ascher NL, Freise CE, Dodge JL, Roberts JP. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation. Liver Transpl, Feb/2012;18(2):160-5. doi: 10.1002/lt.22455.

253. Flohr TR, Bonatti H, Hranjec T, Keith DS, Lobo PI, Kumer SC, Schmitt TM, Sawyer RG, Pruett TL, Roberts JP, Brayman KL. Elderly recipients of hepatitis C positive renal allografts can quickly develop liver disease. J Surg Res, Aug/2012;176(2):629-38.

254. Park SJ, Freise CE, Hirose R, Kerlan RK, Yao FY, Roberts JP, Vagefi PA. Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma. Clin Transplant, Jul/2012;26(4):E359-64. doi: 10.1111/j.1399-0012.2012.01668.x. Epub 2012 Jun 13.

255. Kasiske BL, McBride MA, Cornell DL, Gaston RS, Henry ML, Irwin FD, Israni AK, Metzler NW, Murphy KW, Reed AI, Roberts JP, Salkowski N, Snyder JJ, Sweet SC. Report of a consensus conference on transplant program quality and surveillance. Am J Transplant, Aug/2012;12(8):1988-1997. doi: 10.1111/j.1600-6143.2012.04130.x. Epub 2012 Jun 8.

50 of 60

Prepared: December 9, 2014256. Melcher ML, Leeser DB, Gritsch HA, Milner J, Kapur S, Busque S, Roberts JP, Katznelson S, Bry W, Yang H, Lu A, Mulgaonkar S, Danovitch GM, Hil G, Veale JL. Chain transplantation: initial experience of a large multicenter program. Am J Transplant, 2012 Sep;12(9):2429-36. doi: 10.1111/j.1600-6143.2012.04156.x. Epub 2012 Jul 19

257. Lai JC, Feng S, Roberts JP. An examination of liver offers to candidates on the liver transplant wait-list. Gastroenterology, 2012 Nov;143(5):1261-5. doi: 10.1053/j.gastro.2012.07.105. Epub 2012 Jul 27.

258. Roberts JP. The Impact of Outcomes Monitoring on Innovation and Risk in Liver Transplantation. Liver Transplantation, 2012 Nov;18 Suppl 2:S59-63. doi: 10.1002/lt.23539.

259. Biggins SW, Bambha KM, Terrault NA, Inadomi J, Shiboski S, Dodge JL, Gralla J, Rosen HR, Roberts JP. Projected Future Increase in Aging Hepatitis C Virus–Infected Liver Transplant Candidates: A Potential Effect of Hepatocellular Carcinoma. Liver Transpl. 2012 Dec;18(12):1471-8. doi: 10.1002/lt.23551.

260. Halldorson JB, Paarsch HJ, Dodge JL, Segre AM, Lai J, Roberts JP. Center Competition and Outcomes Following Liver Transplantation. Liver Transpl. Vol 19:96-104, Jan 2013.

261. Lai JC, Feng S, Vittinghoff E, Roberts JP. Offer patterns of nationally placed livers by donation service area. Liver Transpl. 2013 Apr;19(4):404-10. doi: 10.1002/lt.23604. Epub 2013 Mar 17.

262. Hickey MD, Quan DJ, Chin-Hong PV, Roberts JP. Use of rifabutin for the treatment of a latent tuberulosis infection in a patient after solid organ transplantation. Liver Transpl. 2013 Apr;19(4):457-61. doi: 10.1002/lt.23622. Epub 2013 Mar 22.

263. Roll GR, Parekh JR, Parker WF, Siegler M, Pomfret EA, Ascher NL, Roberts JP. Left Hepatectomy Versus Right Hepatectomy for Living Donor Liver Transplantantation: Shifting the Risk From the Donor to the Recipient. Liver Transpl. 2013 May;19(5):472-81. doi: 10.1002/lt.23608. Epub 2013 Apr 15.

264. Teperman L, Moonka D, Sebastian A, Sher L, Marotta P, Marsh C, Koneru B, Goss J, Preston D, Roberts JP. Calcineurin Inhibitor–Free Mycophenolate Mofetil/Sirolimus Maintenance in Liver Transplantation: The Randomized Spare-the-Nephron Trial. Liver Transpl. 2013 Jul;19(7):675-89. doi: 10.1002/lt.23658.

265. Halldorson J, Roberts JP. Decadal analysis of deceased organ donation in Spain and the United States linking an increased donation rate and the utilization of older donors. Liver Transpl. 2013 Sep;19(9):981-6.

266. Rabe IB, Schwartz BS, Farnon EC, Josephson SA, Webber AB, Roberts JP, de Mattos AM, Gallay BJ, van Slyck S, Messenger SL, Yen CJ, Bloch EM, Drew CP, Fischer M, Glaser CA; WNV Transplant Investigation Team. Fatal transplant-associated west nile virus encephalitis and public health investigation-California, 2010. Transplantation. 2013 Sep 15;96(5):463-8.

267. Lai JC, Kahn JG, Tavakol M, Peters MG, Roberts JP. Reducing Infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant. 2013 Oct;13(10):2611-8.

268. Neidich E, Neidich AB, Axelrod DA, Roberts JP. Consumerist responses to scarcity of organs for transplant. Virtual Mentor. 2013 Nov 1;15(11):966-72.

269. Samoylova ML, Dodge JL, Vittinghoff E, Yao FY, Roberts JP. Validating post-transplant hepatocellular carcinoma recurrence data in the UNOS database. Liver Transplantation 2013 Dec;19(12):1318-23.

51 of 60

, 01/03/-1,

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

, 01/03/-1,

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

, 01/03/-1,

Transplantation

, 01/03/-1,


, 01/03/-1,


Prepared: December 9, 2014270. Mehta N, Dodge JL, Goel A, Roberts JP, Hirose R, and Yao FY. Identification of Liver Transplant Candidates With Hepatocellular Carcinoma and a Very Low Dropout Risk: Implications for the Current Organ Allocation Policy. Liver Transplantation. 2013 Dec;19(12):1343-53.

271. Perito ER, Rhee S, Roberts JP, Rosenthal P. Pediatric Liver Transplantation for Urea Cycle Disorders and Organic Acidemias: United Network for Organ Sharing Data for 2002-2012. Liver Transpl 2014 Jan;20(1):89-99.

272. Roll GR, Roberts JP. Left versus right lobe liver donation. Am J Transplant. 2014 Feb;14(2):251-2.

273. Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE. Ex vivo split-liver transplantation: the true right/left split. HPB (Oxford). § 2014 Mar;16(3):267-74.

274. Lai JC, Kahn JG, Roberts JP. Author Response: Reducing Infection Transmission in Solid Organ Transplantation Through Donor Nucleic Acid Testing: A Cost-Effectiveness Analysis. Am J Transplant. 2014 Apr;14(4):981.

275. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Outcome After Liver Transplantation in Patients with Hepatocellular Carcinoma with a Low Risk of Dropout from the Transplant Waiting List. Liver Transplantation. 2014 May;20(5):627-8.

276. Samoylova M, Dodge JL, Yao FY, Roberts JP. Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplant. Liver Transplantation. Aug 2014;20(8):937-944.

277. Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY. Alpha-Fetoprotein Level > 1000 ng/mL as an Exclusion Criterion for LiverTransplantation in Patients With Hepatocellular Carcinoma Meeting the MilanCriteria. Liver Transplantation. Aug 2014;20(8):945-951.

278. Samoylova M, Dodge JL, Mehta N, Yao FY, Roberts JP. Evaluating the Validity of MELD Exception Points for HCC patients with multiple nodules Less Than 2cm. Liver Transplantation (submitted)

279. Vagefi PA, Feng S, Dodge JL, Markmann JF, Roberts JP. Multiple Listings as a Reflection of Geographic Disparity in Liver Transplantation. J Am Coll Surg. 2014 May 2. pii: S1072-7515(14)00360-3. doi: 10.1016/j.jamcollsurg.2014.03.048.

NON-PEER REVIEWED PUBLICATIONS AND OTHER CREATIVE ACTIVITIES:

1. Roberts, JP, Legaspi, AJ, Albert, JD, Legaspi, A, Chiao, J, Lowry, SF, and Shires, GT. Relationship of the change in skeletal muscle transmembrane potential and electrolytes following human burn injury. ACS Surg Forum, 1985;36:105.

2. Roberts, JP, Fryd, DS, Ascher, NL, Migliori, R, Payne, W, Dunn, D, Sutherland, D, Simmons, R, and Najarian J. Living related kidneys continue to provide superior results to cadaveric kidneys in the cyclosporine era. Transplant Proc, 1988;20:26.

3. Roberts, JP, Lake, JR, and Ascher, NL. Liver transplantation: the first twenty-five years. West J Med, 1988;149: 316-321.

4. Stock, PG, Payne, WD, Ascher, NL, Roberts, JP, Belani, K, Estrin, J, and Najarian JS. Rapid infusion technique as a safe alternative to veno-venous bypass in orthotopic liver transplant (TX). Transplant Proc, Feb1989;21(1 Pt 2):2322-5.

52 of 60

, 01/03/-1,

Journal of the American College of Surgeons

, 01/03/-1,

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

, 01/03/-1,

HPB : the official journal of the International Hepato Pancreato Biliary Association.

http://www.ncbi.nlm.nih.gov/pubmed/23601002

Prepared: December 9, 20145. Roberts, JP. Immunosuppressive drugs in liver transplantation. Hospital Therapy, Dec 1989; :43.

6. Cohen, N, Roberts, JP, Gumbert, M, Birnbaum, J, Lim, VL, Falco, D, Ascher, N, and Garovoy, MR. Comparison of ELISA and flow cytometric method in the daily monitoring of soluble interleukin 2 receptors in liver transplant recipients. Transplant Proc, 1991;23(1 Pt 2): 1426.

7. Burke, EC, Martinez, OM, Freise, CE, McVicar, J, Roberts, JP, and Ascher, NL. MHC expression on human hepatocytes before and after isolation. Transplant Proc, Feb 1991;23(1 Pt 2):1428-9.

8. Freise, CE, Hong, K, Clemens, LE, Papahadjopoulos, D, Burke, E, Martinez, O, Lake, J, Ascher NL, and Roberts, JP. Characterization of a cyclosporine-containing liposome. Transplant Proc, Feb 1991;23(1 Pt 1):473-4.

9. Freise, CE, Pons, V, Lake, J, Burke, E, Ascher, NL, and Roberts, JP. Comparison of three regimens for cytomegalovirus prophylaxis in 147 liver transplant recipients. Transplant Proc, Feb 1991; 23(1 Pt 2):1498-500.

10. Hebert, MF, Ascher, NL, Lake, JR, and Roberts, JP. Efficacy and toxicity of FK 506 for the treatment of resistant rejection in liver transplant patients. Transplant Proc, Dec 1991;23(6):3109-10.

11. Freise, CE, Rowley, H, Lake, J, Hebert, M, Ascher, NL, and Roberts, JP. Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. Transplant Proc, Dec 1991;23(6):3173-4.

12. Freise, C, Liu, T, Osorio, R, and Roberts, JP. Increased efficacy of cyclosporine liposomes in a rat orthotopic liver transplant model. Surgical Forum, 1992.

13. Klintmalm, GB, Ascher, NL, Busuttil, R, Delerhoi, M, Gonwa, T, Kauffman, RM, Roberts, JP, McDiarmind, S, Poplawski, S, and Sollinger, H. RS-61443 for treatment-resistant human liver rejection. Transplant Proc, 1993;25(1):697.

14. Klintmalm, GBG, Goldstein, R, Gonwa, T, Wiesner, RH, Krom, RAF, Shaw, BW, Stratta, R, Ascher, NL, Roberts, JP, Lake, JR, Busuttil, RW, McDiarmid, S, Esquivel, CO, Nakazato, P, Marsh, JW, Woodle, ES, Kalayoglu, M, D'Alessandro, AM, Pirsch, JD, Miller, C, Schwartz, M, Lewis, WD, Monaco, AP, Jenkins, RL, Emond, JC, Thistlethwaite, JR, Whitington, PF, Stenmuller, DR, Fitzsimmons, WE, and Lawrence, L. Use of FK506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group. Transplant Proc, 1993; 25(1):635-637.

15. Klintmalm, GB, Goldstein, R, Gonwa, T, Wiesner, RH, Krom, RA, Shaw, BW Jr, Stratta, R, Ascher, NL, Roberts, JP, Lake, J, Busuttil, RW, McDiarmid, S, Esquivel, CO, Nakazato, P, Marsh, JW, Woodle, ES, Kalayoglu, M, D'alessandro, AM, Pirsch, JD, Miller, C, Schwartz, M, Lewis, WD, Monaco, AP, Jenkins, RL, Emond, JC, Thistlethwaite, JR, Whitington, PF, Steinmuller, DR, Fitzsimmons, WE, and Lawrence, L. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Transplant Proc, 1993;25(1 Pt 1):679-88.

16. Klintmalm, GB, Goldstein, R, Gonwa, T, Wiesner, RH, Krom, RA, Shaw, BW Jr, Stratta, R, Ascher, NL, Roberts, JP, Lake, J, Busuttil, RW, McDiarmid, S, Esquivel, CO, Nakazato, P, Marsh, JW, Woodle, ES, Kalavoglu, M, D'Alessandro, AM, Pirsch, JD, Miller, C, Schwartz, M, Lewis, WD, Monaco, AP, Jenkins, RL, Emond, JC, Thistlethwaite, JR, Whitington, PF, Steinmuller, DR, Fitzsimmons, WE, and Lawrence, L . Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Transplant Proc, 1993;25(1 Pt 1):641-3.

17. Lake, JR, Wright, T, Ferrell, L, Donegan, E, Roberts, JP, and Ascher, NL. Hepatitis C and B in liver transplantation. Transplant Proc, 1993;25(2):2006.

53 of 60

Prepared: December 9, 201418. Lake, JR, Ring, E, LaBerge, J, Gordon, R, Roberts, JP, and Ascher, NL. Transjugular intrahepatic portocaval stent shunts in patients with renal insufficiency. Transplant Proc, 1993;25(2):1766.

19. Sollinger, HW, Belzer, FO, Deierhoi, MH, Diethel, AG, Gonwa, TA, Kauffman, RS, Klintmalm, GB, McDiarmid, SV, Roberts, JP, Rosenthal, JT, and Tomlanovich, SJ. RS-61443: rescue therapy in refractory kidney transplant rejection. Transplant Proc, 1993;25(1 Pt 1):698.

20. Krams, SM, Martinez, OM, Villanueva, JC, Lake, J, Roberts, JP, and Ascher, NL. T-cell receptor-V alpha gene use in sequential liver allograft biopsies. Transplant Proc, Feb 1993;25(1 Pt 1):84-5.

21. Martinez, OM, Krams, SM, Villanueva, JC, Ferrell, L, Lake, J, Roberts, JP, and Ascher NL. Intragraft eosinophilia and interleukin-5 mRNA accompany liver allograft rejection. Transplant Proc, Feb 1993;25(1 Pt 1):126-7.

22. Osorio, RW, Freise, CE, Ascher, NL, Roberts, JP, Avery, M, and Lake, JR. Orthotopic liver transplantation for end-stage alcoholic liver disease. Transplant Proc, Feb 1993;25(1 Pt 2):1133-4.

23. Osorio, RW, Ascher, NL, Jaenisch, R, Natuzzi, ES, Freise, CE, Roberts, JP, and Stock, PG. Isolation of functional MHC class I-deficient islet cells. Transplant Proc, Feb 1993;25(1 Pt 2):968-9.

24. Stock, PG, Ascher, NL, Osorio, RW, Tomlanovich, S, Lake, JR, Nikolai, B, Freise, C, and Roberts, JP. Standard sequential immunosuppression with Minnesota antilymphoblast globulin and cyclosporine vs FK 506: a comparison of early nephrotoxicity. Transplant Proc, Feb 1993;25(1 Pt 1):675-6.

25. Freise, CE, Hebert, M, Osorio, RW, Nikolai, B, Lake, JR, Kauffman, RS, Ascher, NL, and Roberts, JP. Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation. Transplant Proc, Apr 1993;25(2):1758-9.

26. Freise, CE, Stock, PG, Roberts, JP, and Melzer, JS. Low postoperative wound infection rates are possible following simultaneous pancreas-kidney transplantation. Transplant Proc, Dec 1995;27(6):3069-70.

27. Pritsker, AAB, Martin, DL, Reust, JS, Wagner, MA, Wilson, JR, Kuhl, ME, Allen, MD, Daily, PO, Harper, AM, Edwards, EB, Bennett, LE, Roberts, JP, and Burdick, JF. Organ transplantation policy evaluation. Winter Simulation Conference Proceeding, 1995; 1313-1323.

* This paper was selected by the Winter Simulation Conference in 2007 as one of 10 landmark papers in the last 40 years for WSC conferences.

28. Emond, JC, Rosenthal, P, Roberts, JP, Stock, PG, Kelley, S, Gregory, G, Lim, RC, and Ascher, NL. Living related donor liver transplantation: the UCSF experience. Transplant Proc, Aug 1996;28(4): 2375-7.

29. Fung, JJ, and Roberts, JP. The rationale for equitable liver allocation. Clin Transpl, 1996;:325-32.

30. Emond, JC, Stock, P, Roberts, JP, and Ascher, NL. Strategies for tolerance induction: potential applications in living donor liver transplantation. Transplant Proc, Aug 1996;28(4): 2371-4. Review.

31. Kita, Y, Lake, JR, Ferrell, LD, Mori, M, Roberts, JP, Kakizoe, S, Kiyosawa, K, Tanaka, E, Shiga, J, Takikawa, H, Inoue, Y, Ohtake, T, Ohtomo, K, Yotsuyanagi, H, Oka, T, Harihara, Y, Takayama, T, Kubota, K, Kawarasaki, H, Hashikura, Y, Kawasaki, S, Ascher, NL, and Makuuchi, M. Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: report of a case. Transplant Proc, Nov 1998;30 (7): 3321-3.

54 of 60

Prepared: December 9, 201432. Narumi, S, Hakamada, K, Sasaki, M, Freise, CE, Stock, PG, Roberts, JP, and Ascher, NL. Liver transplantation for autoimmune hepatitis: rejection and recurrence. Transplant Proc, Aug 1999;31(5):1955-6.

Review Articles

1. Morris PJ, Tilney NL Review of Progress in Pancreatic Islet and Fetal Pancreas Transplantation. Progress in Transplantation. 167: 357-8, 1998.

Books and Chapters

1. Roberts JP, Ascher NL, Payne WD. Clinical and Surgical Considerations in Hepatic Transplantation. Editor(s): Letourneau, JG. Radiology of Organ Transplantation: Mosby Year Book, St. Louis. 161-169, 1991.

2. Ascher NL, Roberts JP. Liver Transplantation. Editor(s): Way, LW. Current Surgical Diagnosis & Treatment: Lange Medical Publications, Los Altos. 1991.

3. Roberts JP. Liver Transplantation, 19th Ed. Editor(s): Wyngaarden, JB, Smith, LH, and Bennett, JC. Cecil Textbook of Medicine: W.B. Saunders Co., Harcourt Brace Jovanovich, Inc., Philadelphia. 799-801, 1992.

4. Roberts JP. Organ Transplantation. Editor(s): Schrock, TR. Handbook of Surgery: Mosby Yearbook, St. Louis. 1992.

5. Roberts JP. Organ Transplantation. Current Diagnosis and Critical Care: Appleton and Lange, 1992.

6. Freise CE, Roberts JP. Organ Transplantation, 10th Ed. Editor(s): Schrock, TR. Handbook of Surgery: Mosby, St. Louis. 1994.

7. Ascher NL, Keith FM, Melzer J, Feduska NJ, Roberts JP. Organ Transplantation, 10th Ed. Editor(s): Way, LW. Current Surgical Diagnosis and Treatment: Lange Medical Publications, Los Altos. 1308-1324, 1994.

8. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver Transplantation at the University of California, San Francisco. Clinical Transplants 1994: UCLA Immunogenetics Center, 175-179, 1994.

9. Pritsker AAB, Martin DL, Reust JS, Wagner MA, Wilson JR, Kuhl ME, Allen MD, Daily, OP, Harper, AM, Edwards EG, Bennett LE, Roberts JP, Burdick JF. 1995: Organ transplantation policy evaluation, 1995 Winter Ed. Editor(s): Alexopoulos C, Kang K, Lilegdon WR, Goldsman D (eds). Proceedings of the 1995 Winter Simulation Conference: IEEE Xplore , 1314-1323, 12/3/1995.

10. Roberts JP. Liver Transplantation, 20th Ed. Editor(s): Bennett, JC, and Plum, F. Cecil Textbook of Medicine: W.B. Saunders Co., Philadelphia. 800-802, 1996.

11. Freise CE, Ascher NL, Roberts JP. Liposomal Cyclosporine. Editor(s): Gruber, S. Local Immunosuppression of Organ Transplants: R.G. Landes Co., 109-118, 1996.

12. Ascher NL, Roberts JP. Rejection after Transplantation. Editor(s): Busuttil, RW, and Klintmalm, GB. Transplantation of the Liver: W.B. Saunders Co., Philadelphia. 265-273, 1996.

13. Ferrell LD, Roberts JP. Liver. Editor(s): Ranchod, M. Intraoperative Consultations in Surgical Pathology: State of the Art Reviews: Hanley & Belfus, Inc., Philadelphia. 367-378, 1996.

55 of 60

Prepared: December 9, 201414. Roberts JP. Prioritization and Distribution of Organs for Liver Transplantation. Editor(s): Klintmalm, G, and Sollinger, H. Recent Developments in Transplantation Medicine: Physicians & Scientists Publishing Co., Glenview. III: 145-154, 1996.

15. Fung JJ, Roberts JP. The Rationale for Equitable Liver Allocation, Current Opinions. Clinical Transplants 1996: UCLA Immunogenetics Center, 1996.

16. Roberts JP. Organ Sharing and Allocation. Editor(s): Norman, DJ, and Suki, WD. Primer on Transplantation: American Society of Transplant Physicians, Thorofare. 283-288, 1998.

17. Roberts JP, Brown RS, Jr. Economics of Liver Transplantation. Editor(s): Norman, DJ, and Suki, WD. Primer on Transplantation: American Society of Transplant Physicians, Thorofare. 289-292, 1998.

18. Roberts JP. Liver Transplantation, 21st Ed. Editor(s): Goldman, L, and Bennett, JB. Cecil Textbook of Medicine: W.B. Saunders Co., Philadelphia. 2: 816-818, 2000.

19. Roberts JP, Ascher NL, Feduska NJ, Keith FM, Melzer J, Salvatierra O, Jr. Organ Transplantation, 11th Ed. Editor(s): Way, LW, and Doherty, GM. Current Surgical Diagnosis and Treatment: The McGraw Hill Companies, New York. 1372-1386, 2003.

20. Lipshutz GS, Ascher NL, Roberts JP. Rejection after Transplantation, 2nd Ed. Editor(s): Busuttil, RW, and Klintmalm, GB. Transplantation of the Liver: Elsevier Saunders, Philadelphia. 1167-1182, 2005.

21. Kashef Elika, Roberts JP. Hepatocellular carcinoma. In: Yeo, C. (Ed) Shackelford's Surgery of the Alimentary Tract. 6th ed. Philadelphia, PA: Elsevier; 2007.

22. Roll GR, Roberts JP. Liver transplantation for hepatocellular carcinoma (Ch 97D). In: Jarnagin WR, Belghiti J, Buchler MW, Chapman WC, D'Angelica MI, De Matteo RP, Hann LE, Blumbart LH (eds). Blumgart's Surgery of the Liver, Biliary Tract and Pancreas. Vol II. 5th ed. Philadelphia, PA:Elsevier Saunders; 2012:1701-1711.

ABSTRACTS

1. Hebert MF, Roberts JP, Gambertoglio JG, and Benet LZ "The effects of rifampin on cyclosporine pharmacokinetics." American Society for Clinical Pharmacology and Therapeutics. 1991.

2. Ferrell L, Steinkirchner T, Sterneck M, and Roberts JP "Alpha-1-antitrypsin globules in cirrhotic livers." Academy of Pathology. 1992.

3. Ferrell L, Cregan P, Wright S, and Roberts JP "Predictive value of pretransplant liver biopsy in patietns with fulminnt hepatitis." Academy of Pathology. 1992.

4. Osorio RW, Avery M, Ascher NL, Roberts JP, and Lake JR "Predicting recidivism after orthotopic liver transplantation." Pacific Coast Surgical Association. 1992.

5. Liu T, Osorio R, Ascher N, and Roberts JP "Orthotopic liver transplantation for fulminant hepatic failure in rats." Transplant and Associated Immunology. 1992.

56 of 60

Prepared: December 9, 20146. Yao FY, Bass NM, Nikolai B, Davern TJ, Wu V, Moore B, Ascher NL, and Roberts JP "Liver transplantation for hepatocellular carcinoma - analysis of survival according to intention-to-treat, and the rate of "drop-out" from the waiting list." Hepatology. Vol. 34: 174A, 2001.

7. McTaggart RA, Gottlieb D, Brooks JH, Bacchetti PB, Roberts JP, Tomlanovich SJ, and Feng S. "Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation." Am J Transplant. Abstract # 550 Vol. 2 ((s3)) : 2002, 2002.

8. McTaggart RA, Bostrom A, Bacchetti PB, Roberts JP, Tomlanovich S, Feng S. "Prolongation of delayed graft function by sirolimus does not adversely affect transplant outcomes." Am J Transplant. Abstract # 1602 Vol. 3 ((s5)) : 563, 2003.

9. Barry CT, Liu T, Roberts JP, Hirose R, and Niemann CU "Expression of surviving an anti-apoptosis gene, in a fatty rat cold ischemia model." HBP Surgery. Vol. 6 (S1) : 135,37, 2004.

10. Niemann CU, Liu T, Brown JL, Robertrs JP, Hirose R, and Serkova N. "Ischemic preconditioning improves metabolic profiles during cold ischemia and survival after transplantation utilizing fatty donor livers." HPB Surgery. Vol. 6 (S1) : 136,37, 2004.

11. Choi SJN, Noh JH, Niemann CU, Bedolli M, Serkova N, Roberts JP and Hirose R "Mild hypothermia provides significant protection against ischemia/reperfusion injury in rat livers." Liver Transpl. Vol. 10 (6) : 12, C3 ILTS, 2004.

12. Choi SJN, Noh JH, Niemann CU, Serkova N, Roberts JP and Hirose R "Mild hypothermia provides significant protection against ischemia/reperfusion injury in fatty livers." Am J Transpl. Vol. 4 (S8) : 296, 238, ASTS, 2004.

13. Si M, Rosenthal P, McBride MA, Taranto SE, Mudge C, Stritzel S, Roberts JP, Feng S. "Trends over a decade of pediatric liver transplantation in the United States." Am J Transplant. Abstract # 876 Vol. 4 ((s8)) : 397, 2004.

14. Barry CT, McTaggart RA, Roberts JP, Feng S. "Gene expression profiling of liver regeneration in a mouse hepatectomy model." Am J Transplant. Abstract # 1124 Vol. 4 ((s8)) : 466, 2004.

15. McTaggart RA, Feng S, Carter JT, Vardanian A, MacLeod D, Rahmaoui A, Ascher NL, Freise CE, Roberts JP. "Biliary complications in 56 adult living donor liver transplants." Am J Transplant. Abstract #87 Vol. 4 ((s8)) : 182, 2004.

16. McTaggart RA, Feng S, Carter JT, Vardanian A, MacLeod D, Rahmaoui A, Ascher NL, Freise CE, Roberts JP. "Biliary complications in 56 adult living donor liver transplants." Am J Transplant. Abstract #87 Vol. 4 ((s8)) : 182, 2004.

17. McTaggart RA, Ferrell L, Lassman C, Bostrom A, Bacchetti P, Terrault NA, Roberts JP, Feng S. "Acute rejection or recurrent hepatitis C: can liver biopsy make the diagnosis?" Am J Transplant. Abstract #732 Vol. 4 ((s8)) : 182, 2004.

18. McTaggart RA, Ferrell L, Lassman CR, Roberts JP, Terrault NA, Feng S. "The reliability of liver biopsy to diagnose acute rejection: the impact of recurrent hepatitis C." Hepatology. Abstract #441 Vol. 40 ((4) (Suppl 1)) : 356A, 2004.

19. Feng S, McBride MA, Taranto SE, Mudge C, Stritzel S, Rosenthal P, Roberts JP "Trends over a decade of liver transplantation for biliary atresia in the United States." Hepatology. Abstract #715 Vol. 40 ((4) (Suppl 1)) : 474A, 2004.

57 of 60

Prepared: December 9, 201420. Yeh BM, Joe BN, Roberts JP, Westphalen A, Freise C and Coakley FV "Does lowering the kVp improve duct visualization at CT cholangiography for liver donors?" Radiology. Vol. 237 (P) : 193-194, 2005.

21. Yeh BM, Roberts JP, Joe BN, Westphalen A, Freise C and Coakley FV "Can preoperative CT cholangiography predict bile duct complications in right lobe liver transplants?" Radiology. Vol. 237 (P) : 256, 2005.

22. Carter J, Chan S, Roberts J, Feng S. "Expanded criteria donor allocation: dramatic reduction in cold ischemia time and delayed graft function at a single center." Am J Transplant. Abstract #943 Vol. 5 ((s11)) : 396, 2005.

23. Landry GM, Ferrell L, Bostrom A, Roberts JP, Feng S. "Chronic rejection after liver transplantation: incidence, risk factors, and outcomes in the era of tacrolimus/MMF and interferon." Hepatology. Abstract #335 Vol. 42 ((4) (Suppl 1)) : 328A, 2005.

24. Tan V, Terrault N, Agudelo E, Ferrell L, Roberts JP, Feng S. "Long-term histological outcomes after achievement of sustained virological response in liver transplant recipients with recurrent hepatitis C virus infection." Am J Transplant. Abstract #1402 Vol. 6 ((s2)) : 538, 2006.

25. Yao FY, Hirose R, Kerlan RK, Davern TJ, Merriman R, Feng S, Peters M, Friese C, Ascher NL, Bass NM, Roberts JP. "Follow-up analysis of a prospective study on down-staging of hepatocellular carcinoma prior to liver transplantation." Hepatology. Abstract #19 Vol. 44 ((4) (Suppl 1)) : 195A, 2006.

26. Feng S, Meo N, Roberts J. "Recipient rather than donor factors determine liver transplant length of stay at a large volume single center." Am J Transplant. Abstract #181 Vol. 7 ((Suppl 2)) : 193, 2007.

27. Tan V, Roberts J, Feng S. "Steroid and/or antibody treatment of rejection does not accelerate post-transplant hepatitis C progression at a large volume single center." Am J Transplant. Abstract #569 Vol. 7 ((Suppl 2)) : 296, 2007.

RESEARCH PROGRAM

Public Policy

Organ allocation policies for patients awaiting transplantation have been a source of great controversy as they affect patients' lives, transplant centers and the government. Currently, a government contractor, the United Network for Organ Sharing (UNOS) manages the contract for the OPTN, the entity that determines organ allocation policies. The OPTN has been essentially responsible for organ allocation since 1988 and has develops allocation and distribution policies based upon input from its committees. I served on several different UNOS committees and as Chair of the Liver Committee from 1993 to 1995.

Prior to 1995, decisions about creation and modification of policy were based upon trial and error methods, where proposed policies were implemented without any method of predicting in advance the effect of the policy on organ allocation. Because of the uncertainty of predicting the effect of policy changes, it became paramount to develop a computer model for organ allocation.

Predictive models can be created if the events in question can be described from past experience. Because organ allocation is the matching the organs to the patients, the variables that describe the patients and the organ allow the creation of a model. Patients who need transplants can be described in terms of their degree of illness, age, the transplant center they are listed with, and many other variables. Organ donors can be described by similar information.

By using the descriptions of patients and organs, a computer model can be created to predict the effect of the change in organ allocation policy upon the national use of the organs. UNOS has now implemented this system for organ allocation.

58 of 60


I have continued my interest in the creation of public policy regarding organ transplantation. I served as the chairman of the Scientific Advisory committee for the Scientific Registry of Transplant Recipients (SRTR). This committee directs the formation of policy regarding the study of outcomes of patients on the waiting list and after transplantation

In collaboration with the principals at the SRTR, I wrote the paper regarding correcting racial disparities in organ allocation that was the lead article in the NEJM. The findings of this study resulted in a significant change in the manner that kidneys are allocated for transplantation in the US.

My research continues to focus on improving organ allocation.

Hepatocellular Carcinoma

Liver transplantation has become a mainstay in the management of many patients with hepatocellular carcinoma. In collaboration with Dr. Francis Yao, I have published on the selection of patients for transplantation, the management of patients on the waiting list, and the post-transplant outcomes. This work has been recognized internationally in the debate about which patients should be selected for transplantation. The "UCSF Criteria" have been debated as a replacement for the current criteria, "Milan Criteria." Because of the practice of naming of criteria for the center where they were developed, "UCSF" has been discussed extensively in this literature and in public debate

SIGNIFICANT PUBLICATIONS

1. Roberts JP, Wolfe RA, Bragg-Gresham JL, Rush SH, Wynn JJ, Distant DA, Ashby VB, Held PJ, Port FK. Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. N Engl J Med, Feb/5/2004;350(6):545-51.

This paper was the lead article in the New England Journal of Medicine. It caused a change in organ allocation policy that has proven to be beneficial. I conceived of the change in the allocation system, reviewed the data, and I wrote the paper. A follow-up paper demonstrated that the policy change had the predicted effect: Ashby VB, Port FK, Wolfe RA, Wynn JJ, Williams WW, Roberts JP, Leichtman AB. Transplanting kidneys without points for HLA-B matching: consequences of the policy change. Am J Tansplant, Aug/2011;11(8):1712-18.

2. Ponrartana S, Coakley FV, Yeh BM, Breiman RS, Qayyum A, Joe BN, Poder L, Lu Y, Gibbs VC, Roberts JP. Accuracy of plain abdominal radiographs in the detection of retained surgical needles in the peritoneal cavity. Ann Surg, Jan/2008;247(1):8-12.

I conceived of the idea for this study, helped with the model development and data analysis, and I edited the paper.

3. Botha JF, Langnas AN, Campos BD, Grant WJ, Freise CE, Ascher NL, Mercer DF, Roberts JP. Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl, May/2010;16(5):649-57.

This was a collaborative paper between the University of Nebraska and UCSF. This was a demonstration of a protective value of portacaval shunt allowing the use of smaller grafts for living donor liver transplantation. The smaller graft sizes can be obtained from the donor at lower donor mortality and morbidity risk. I conceived of the goal to combine the centers' data, and I helped with the data analysis and manuscript preparation.

4. Roberts JP, Venook A, Kerlan R, Yao F. Hepatocellular carcinoma: ablate and wait versus rapid transplantation. Liver Transpl, Aug/2010;16(8):925-29.

59 of 60

Prepared: December 9, 2014This paper was a summary of a new strategy of managing patients with hepatocellular carcinoma to decrease post transplant recurrence. This was based upon previous work from references # 135, 145, 151, 179, 188, and 213. I conceived of the idea and wrote the paper. The previous studies were in collaboration with Dr. Francis Yao.

5. Washburn K, Pomfret E, Roberts J. Liver allocation and distribution: possible next steps. Liver Transpl, Sep/2011;17(9):1005-1012.

This was a position paper regarding change in liver allocation in the United States. I wrote a substantial portion of this paper.

60 of 60